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Abstract 
 
Caspases are cysteine aspartyl-specific proteases that have been highly conserved 
throughout evolution. They became known by their involvement in apoptosis and 
inflammation, although their participation in other biological processes is presently well 
established. Nevertheless, they are still usually classified as apoptotic or pro-
inflammatory. Apoptotic caspases have been further subdivided into (i) upstream initiator 
caspases (caspase-2, -8, -9 and -10) and (ii) downstream executioner or effector 
caspases (caspase-3, -6 and -7). Initiator caspases are more specialised to cleave their 
own precursors, downstream effector caspases and a small number of other substrates, 
whereas effector caspases cleave cellular proteins, leading to cellular destruction, 
although they can also activate other caspases. Pro-inflammatory caspases (caspase-1,   
-4, -5, -11 and -12) play a crucial role in the processing of inflammatory cytokines. 
Caspases are expressed as pro-enzymes that are composed of a NH2-terminal 
pro-domain highly variable in sequence and length and involved in the regulation of the 
pro-enzyme activation, a large subunit (p20) containing the active site cysteine within a 
conserved QAC(G/R/Q/)G motif, and a small subunit (p10). Some pro-caspases have also 
a short linker between the large and small subunits. Pro-caspases are activated by 
proteolytic processing at the carboxyl side of a specific aspartic acid (Asp) residue in 
response to several internal or external stimuli, resulting in the removal of the NH2-
terminal pro-domain and the formation of a heterotetramer composed of two p20 and two 
p10 subunits with two active sites, that seem to function independently, at opposite ends 
of each molecule. Similarly, caspases have high specificity to cleave their substrates at a 
specific Asp residue that must be in the context of a tetrapeptide motif. The tetrapeptide 
motifs recognised by different caspases differ significantly, explaining the diversity of their 
biological functions.  
Activation of initiator apoptotic and pro-inflammatory caspases occurs at 
multiprotein complexes, known as DISC for caspase-8, apoptosome for caspase-9, and 
inflammasome for caspase-1. By increasing the local concentration of the pro-caspases, 
those multiprotein platforms allow the auto-activation of the caspases through a proximity-
induced dimerization mechanism. Effector caspases do not need such a complex 
mechanism of activation because they are usually activated through proteolytic 
processing by previously activated caspases or other proteases, such as Granzyme B. 
Therefore, caspases form a cascade of proteolytic events, where the initiator caspases 
start the dead effector machinery whereas the effector caspases mostly cleave critical 
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cellular substrates, leading to the biochemical and morphological alterations of the 
apoptosing cells.  
 Caspase activity is tightly regulated at different levels, from gene expression to 
several steps of the caspase production, processing and activity. The activation of the 
apoptotic program, in response to a death signal, is regulated by an accurate balance 
between the pro-apoptotic and anti-apoptotic mechanisms, in which the Bcl-2 family 
members play a crucial role by regulating the mitochondrial outer membrane 
permeabilization (MOMP), which allows the release of several regulatory proteins from the 
mitochondrial intermembrane space. Along with the regulation through different protein 
factors, the caspase activities can also be regulated by the presence of isoforms. 
 While the involvement of caspases in several biological processes was well 
established in mammals when this work started, the information on fish caspases was 
scarce, with only few fish caspases known and characterised. Given the importance of 
fish research to support the much needed development of aquaculture and to study 
diverse mammalian normal and pathological issues, and given the participation of 
apoptosis and inflammation in many biological processes and pathologies in vertebrates, 
research on fish caspases is of obvious relevance. This thesis was developed at the Fish 
Immunology and Vaccinology group of the IBMC that, during the last years, has been 
using sea bass to study the Photobacterium damselae ssp. piscicida pathogenicity 
mechanism as an example of a bacterial infection where the pathogen subverts the 
apoptotic and pro-inflammatory machineries of the host. The work plan of this thesis was 
developed in this context, aiming at cloning, sequencing and genetically characterise sea 
bass caspases representing all functional classes. 
The initiator caspases of the extrinsic and intrinsic pathways, caspase-8 and -9, 
respectively, as well as the central executioner of apoptosis, caspase-3, were identified in 
sea bass. At the molecular level, the obtained sequences of sea bass caspase-8, -9 and   
-3 retain the motifs that are functionally important, such as the pentapeptide active-site 
motif (QACXG) and the cleavage sites at the aspartic acids that give rise to the 
characteristic organisation in NH2-terminal pro-domain and large and small subunits. In 
sea bass caspase-8, two death effector domains (DED) were predicted by bioinformatics 
analysis. The same approach identified a caspase recruitment domain (CARD) in the 
NH2-terminal pro-domain of sea bass caspase-9. Both DED and CARD are important 
domains involved in protein-protein interactions necessary to mediate dimerization and 
consequent activation of caspase-8 and -9, respectively. It was also shown that sea bass 
caspase-8,   -9 and -3 were expressed at low levels in several organs of non-stimulated 
sea bass, and that their expression was up-regulated in the spleen in response to 
apoptotic stimuli. These data added to the understanding of the biology of fish apoptotic 
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caspases and allowed the development of tools to study the mechanisms of apoptosis in 
sea bass. 
In this work, the sea bass caspase-1 gene was also cloned, sequenced and 
characterised. It was shown that sea bass caspase-1 auto-processing is similar to the one 
of its mammalian homologue, resulting in active p24/p10 and p20/p10 heterodimers. The 
presence of alternative spliced variants of caspase-1 in sea bass was also reported. The 
existence of caspase-1 isoforms in fish and in mammals suggests that they have been 
evolutionarily maintained and therefore are likely to play a regulatory role in the 
inflammatory response. The involvement of caspase-1 in the processing of inflammatory 
cytokines in non-mammalian vertebrates has been a matter of debate. This work 
contributed to clarify this issue, by showing that sea bass and avian IL-1β are specifically 
cleaved by caspase-1 at different but phylogenetically conserved aspartates, distinct from 
the cleavage site of mammalian IL-1β. 
In conclusion, the sea bass counterparts of mammalian apoptotic caspases-8, -9 and 
-3 as well as the pro-inflammatory caspase-1, were sequenced and characterised. This 
allowed the production of new tools that were used to study the involvement of sea bass 
caspases in apoptotic processes and to biochemically characterise the sea bass caspase-
1. In the future, these tools can also be used to better understand the role of caspases in 
apoptotic and inflammatory processes in fish, as well as to investigate their participation in 
other biological processes. Additionally, the recognition that the caspase-1 from a teleost 
fish is able to specifically process the proIL-1β into its mature form opens new doors to the 
study of the role of caspase-1 in immunological processes in non-mammalian vertebrates. 
In recent years, the importance of the inflammasomes in different pathologies, such as 
autoinflammatory and infection diseases, has been revealed. In several infections of 
mammals, it has been reported that the activation of inflammasomes is accompanied by 
the induction of pyroptosis, in an attempt to limit the pathogen replication. However, so far 
there are no data regarding inflammasomes or pyroptosis in any species of fish. Exploring 
the molecular mechanisms of caspase-1 activation at the inflammasomes as well as the 
subversion of the inflammasome pathways by pathogens appear as new lines of research 
in fish. Finally, it is worth mentioning that there are new insights in the regulation of 
caspases by their isoforms in mammals and thus, the study of the role of sea bass 
caspase-1 isoforms in the regulation of caspase-1 activity is of great interest. 
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Resumo 
 
 As caspases são proteases cisteínicas com especificidade para aspartatos 
extremamente conservadas ao longo da filogenia. Tornaram-se conhecidas 
principalmente devido ao seu envolvimento na apoptose e inflamação embora, hoje em 
dia, a sua participação noutros processos biológicos esteja bem documentada. Ainda 
assim, as caspases continuam a ser classificadas como apoptóticas ou pró-inflamatórias. 
As caspases apoptóticas podem ser subdivididas em (i) iniciadoras (caspase-2, -8, -9 e    
-10) e (ii) executoras ou efetoras (caspase-3, -6 and -7). As caspases iniciadoras são 
mais especializadas em clivar os seus próprios precursores, as caspases efetoras e um 
pequeno número de outros substratos, enquanto que as caspases efetoras estão 
sobretudo envolvidas na clivagem de vários substratos celulares, levando às alterações 
morfológicas típicas da apoptose. As caspases pro-inflamatórias (caspase-1, -4, -5, -11 e 
-12) têm uma função crucial no processamento de citoquinas inflamatórias. 
 As caspases são sintetizadas como pro-enzimas compostas por um pro-domínio 
amino-terminal extremamente variável em sequência e tamanho e envolvido na regulação 
da ativação da pro-enzima, uma subunidade grande (p20) contendo a cisteína reativa no 
contexto de um motivo QAC(G/R/Q/)G conservado, e uma subunidade pequena (p10). 
Algumas pro-caspases também têm um pequeno fragmento de ligação entre as 
subunidades grande e pequena. Em resposta a diversos estímulos externos ou internos, 
as pro-caspases são ativadas por processamento proteolítico específico no lado carboxilo 
de um resíduo de ácido aspártico (Asp), resultando na remoção do pro-domínio e na 
formação de um hetero-tetrâmero com dois locais ativos, composto por duas 
subunidades p20 e duas subunidades p10. As caspases clivam os seus substratos num 
resíduo Asp específico que tem de estar no contexto de um motivo tetrapeptídico. 
Diferentes caspases reconhecem motivos tetrapeptídicos distintos, estando esta 
diferença na base da diversidade das funções biológicas das caspases.  
 A ativação das caspases apoptóticas iniciadoras e das caspases pró-inflamatórias 
ocorre em complexos multiproteicos, conhecidos como DISC para a caspase-8, 
apoptosoma para a caspase-9, e inflamasoma para a caspase-1. As referidas 
plataformas multiproteicas conduzem a um aumento da concentração local das pro-
caspases, permitindo a auto ativação das mesmas por um mecanismo de dimerização 
induzido por proximidade. As caspases efetoras não necessitam de um mecanismo tão 
complexo de ativação, uma vez que são normalmente ativadas por processamento 
proteolítico efetuado por caspases previamente ativadas ou por outras proteases, como 
por exemplo a Granzima B. Desta forma, as caspases formam uma cascata de eventos 
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proteolíticos, onde as caspases iniciadoras despoletam a maquinaria efetora da morte, 
enquanto que as caspases efetoras clivam principalmente substratos celulares, levando à 
ocorrência das alterações bioquímicas e morfológicas características da apoptose.  
 A atividade das caspases encontra-se altamente regulada a vários níveis, desde a 
sua expressão genética até aos vários passos da sua produção, processamento e 
atividade. A ativação do programa apoptótico, em resposta a um sinal de morte, está 
regulada por um balanço preciso entre os mecanismos pro-apoptóticos e anti-
apoptóticos, no qual os membros da família Bcl-2 têm um papel fundamental através da 
regulação da permeabilização da membrana externa mitocondrial (MOMP), a qual 
permite a saída de diversas proteínas reguladoras do espaço intermembranar da 
mitocôndria. Para além da regulação efetuada através de diferentes fatores proteicos, as 
atividades das caspases também são reguladas por isoformas. 
 Aquando do início do presente trabalho, o envolvimento das caspases dos 
mamíferos em diversos processos biológicos estava bem documentado. No entanto, a 
informação relativa às caspases dos peixes era bastante limitada, e apenas algumas 
caspases de peixes tinham sido identificadas e caracterizadas. Dada a importância da 
investigação em peixes, não só para apoiar o desenvolvimento da aquacultura mas 
também como contribuição para o estudo de diversos aspetos fisiológicos e patológicos 
em mamíferos, e dada a participação da apoptose e inflamação em vários processos 
biológicos e patologias de vertebrados, a investigação das caspases em peixes é, 
obviamente, relevante. O presente trabalho foi desenvolvido no grupo de Imunologia e 
Vacinologia de Peixes do IBMC que, durante os últimos anos, tem vindo a usar o robalo 
para estudar o mecanismo de patogenicidade da Photobacterium damselae ssp. piscicida 
como um exemplo de uma infeção bacteriana onde o agente patogénico subverte as 
maquinarias apoptótica e pro-inflamatória do hospedeiro. O plano de trabalho desta tese 
foi desenvolvido nesse contexto, tendo como objetivo a clonagem, sequenciação e 
caracterização genética de representantes de todas as classes de caspases no robalo. 
 As caspases iniciadoras da via extrínseca e intrínseca, caspase-8 e -9, 
respetivamente, assim como a principal caspase executora da apoptose, a caspase-3, 
foram identificadas no genoma do robalo. A nível molecular, as sequências da caspase-8, 
-9 e -3 obtidas retêm os motivos que são funcionalmente importantes, tais como o motivo 
catalítico pentapeptídico (QACXG) e os locais de processamento (em ácidos aspárticos) 
que resultam na organização característica das caspases em pro-domínio, grande e 
pequena subunidades. Na caspase-8 de robalo, dois domínios efetores de morte (DED) 
foram previstos por análise bioinformática. A mesma abordagem permitiu identificar um 
domínio de recrutamento de caspases (CARD) no pro-domínio da caspase-9 de robalo. 
Tanto o DED como o CARD são domínios importantes envolvidos em interações 
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proteína-proteína necessários para mediar a dimerização e consequente ativação das 
caspases-8 e -9, respetivamente. Dados obtidos durante este trabalho revelaram baixos 
níveis de expressão das caspases-8, -9 e -3 em diversos órgãos de robalo não 
estimulados e um aumento de expressão das mesmas no baço em resposta a um 
estímulo apoptótico. Este trabalho originou informação que contribuiu para uma melhor 
compreensão da biologia das caspases em peixes e que permitiu o desenvolvimento de 
ferramentas para estudar os mecanismos da apoptose em robalo. 
 Neste trabalho, o gene da caspase-1 de robalo foi também clonado, sequenciado 
e caraterizado. Foi mostrado que a caspase-1 de robalo é auto-processada de forma 
semelhante à da sua homóloga de mamíferos, resultando em heterodímeros ativos de 
p24/p10 e p20/p10. A existência de variantes da caspase-1 originadas por 
processamento alternativo em robalo foi também reportada. A existência de isoformas da 
caspase-1 em peixes e em mamíferos sugere que foram mantidas durante a evolução 
filogenética e portanto muito provavelmente desempenham uma função reguladora na 
resposta inflamatória. O papel da caspase-1 no processamento de citoquinas 
inflamatórias em vertebrados que não mamíferos tem vindo a ser objeto de intenso 
debate. Os resultados aqui apresentados contribuíram para clarificar essa questão, uma 
vez que mostraram que as IL-1β de robalo e de aves são clivadas especificamente pela 
caspase-1 em aspartatos conservados filogeneticamente, distintos do local de clivagem 
presente na IL-1β de mamíferos.  
 Em conclusão, as caspases apoptóticas-8, -9 e -3 assim como a caspase-1 do 
robalo, foram sequenciadas e caracterizadas. A identificação destas caspases em robalo 
permitiu a produção de novas ferramentas que foram usadas para estudar o 
envolvimento das caspases de robalo em processos apoptóticos e para caracterizar 
bioquimicamente a caspase-1. No futuro, estas ferramentas poderão ser aplicadas na 
clarificação do envolvimento das caspases do robalo em mais situações envolvendo 
processos apoptóticos e/ou inflamatórios assim como no estudo de outras funções 
desempenhadas pelas caspases. Adicionalmente, a demonstração de que a caspase-1 
de um peixe teleósteo processa a proIL-1β na sua forma matura abre portas ao estudo do 
papel da caspase-1 em processos imunológicos em vertebrados que não mamíferos. Nos 
últimos anos, tornou-se evidente a importância dos inflamasomas em diversas patologias, 
tais como doenças auto-imunes e infeciosas. Em diversas infeções de mamíferos, foi 
mostrado que a ativação dos inflamasomas é acompanhada pela indução de piroptose, 
como tentativa do hospedeiro controlar a replicação do agente infecioso. No entanto, em 
peixes, não existem quaisquer dados no que respeita a inflamasomas ou piroptose. A 
clarificação dos mecanismos moleculares envolvidos na ativação da caspase-1 ao nível 
dos inflamasomas nos peixes, assim como a subversão os inflamasomas por diferentes 
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agentes patogénicos, apresentam-se como novas linhas de investigação que podem vir a 
ser exploradas no futuro. Por último, é de salientar que há dados recentes sobre novos 
mecanismos de regulação das caspases de mamíferos pelas suas isoformas e, assim 
sendo, o estudo do papel das isoformas da caspase-1 do robalo na regulação da 
atividade da caspase-1 é de grande importância. 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER I 
Introduction* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Parts of this chapter were adapted from dos Santos NM, do Vale A, Reis MI, Silva MT. 
Fish and apoptosis: molecules and pathways. Current Pharmaceutical Design (2008) 
14(2):148-69 (Annex I). 
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Introduction 
 
1. Caspases 
 The family of intracellular Cysteine Aspartyl-Specific Proteases, known as 
caspases, is highly conserved in multicellular organisms and their members share 
common features such as having high specificity to cleave their substrates after aspartic 
acid (Asp) residues [1]. Caspases are usually described as being the key players 
responsible for the morphological and biochemical changes occurring during apoptosis 
(Box 1). Nevertheless, when the first caspase was identified, there was no indication of its 
involvement in apoptosis. In 1992, the mammalian interleukin-1 beta (IL-1β) converting 
enzyme (ICE or caspase-1) was cloned and described as being responsible for the 
processing of pro-inflammatory cytokines, in particular interleukin-1 beta, into their active 
forms [2, 3]. The association of a caspase to cell death was reported for the first time one 
year later, when the ced-3 gene, the mammalian caspase-9 homolog, was cloned in the 
nematode Caenorhabditis elegans and was shown to encode a protein that was 
implicated in cell death [4]. The crucial role of caspases in apoptosis and inflammation is 
well recognised almost since their discovery and recent and very elegant studies have, 
associated apoptotic caspases with the regulation of multiple cellular processes beyond 
cell death, such as cell migration, proliferation and differentiation, thus amplifying the 
functions of the apoptotic caspases to non-apoptotic purposes [5-9]. Nowadays, the idea 
that caspases are important proteins involved in a wide range of biological reactions 
besides cell death is well established [6, 8, 9]. For this reason, the interest to understand 
what drives the activation and regulation of caspases increased and currently caspases 
are among the most studied proteins in science biology, with thousands of scientific 
papers on the subject being publish every year.  
 
1.1. Classification 
All caspases share similarities in amino acid sequence, structure and substrate 
specificity [10]. These proteases are constitutively expressed as zymogens (pro-enzymes) 
of about 30 to 55 kDa and are composed of a NH2-terminal pro-domain, which is highly 
variable in sequence and length and is involved in the regulation of the pro-enzyme 
activation, a large subunit of approximately 20 kDa (p20) containing the cysteine active 
site within a conserved QAC(G/R/Q/)G motif, and a C-terminal small subunit of 
approximately 10 kDa (p10) (Figure 1). Some pro-caspases have also a short linker of 
about 10 amino acids between the large and small subunits [10-13]. Functionally, 
caspases can be classified as apoptotic or pro-inflammatory.  
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Box 1. Apoptosis 
Apoptosis [14] is a genetically controlled and evolutionarily conserved form of active cell death, with an 
increase in complexity during phylogeny. Apoptosis is critical in the elimination of redundant, ectopic, 
damaged, mutated or infected cells and, therefore, plays an essential role in normal development, tissue 
homeostasis and immunity [7, 15-17]. Cells dying by apoptosis shrink and loose the connections with the 
surrounding cells. In general, organelles remain intact in the cytoplasm, despite some observations that 
describe an increase in endoplasmic reticulum size, the release and aggregation of ribosomes, the 
enlargement of the cisternae to form vesicles and vacuoles and the occurrence of changes in the mitochondria 
network [18, 19]. The main changes in the nucleus involve the chromatin condensation (pyknosis), DNA 
fragmentation by endonucleases into small fragments and nuclear fragmentation (karyorrhexis) [19]. Finally, 
the blebbing of the plasma membrane of the cell that has already lost the contact with their neighbours 
becomes perceptive. In some cases, the cell breaks into small fragments of various sizes containing the 
cellular contents and surrounded by membrane (apoptotic bodies) [19]. Apoptotic cells and apoptotic bodies 
are, in vivo, engulfed and digested mainly by macrophages, resulting in the elimination of the dying cells 
before they lyse and, therefore, without induction of an inflammatory response [14, 19-22]. In mammals, 
apoptosis may follow two principal pathways (Box 2): (i) the extrinsic/death-receptor pathway, initiated at the 
tumour necrosis factor (TNF) family receptors or at the dependence receptors [23] and (ii) the intrinsic/Bcl-2-
regulated/mitochondrial pathway, regulated by the Bcl-2 family proteins and mainly characterised by 
mitochondrial membrane permeabilization (MMP) [23].  
 
 
 
Apoptotic caspases can be further subdivided into: i) upstream initiator caspases 
(caspase-2, -8, -9 and -10) and (ii) downstream executioner or effector caspases 
(caspase-3, -6 and -7). The pro-forms of the initiator caspases possess large NH2-
terminal pro-domains, containing either death effector domains (DED) (caspases-8 and -
10) or a caspase-associated recruitment domain (CARD) (caspases-2 and -9); these 
domains are responsible for the interaction with upstream adaptor molecules and thereby 
Adapted from [24] Cells undergoing apoptosis in response to the apoptogenic toxin AIP56 [25]. 
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have a relevant role in the activation of these caspases. The initiator caspases are more 
specialised to cleave their own precursors, downstream effector caspases and a small 
number of other substrates [13, 26]. The executioner or effector caspases have pro-forms 
containing only short NH2-terminal pro-domains thought to be involved in subcellular 
targeting. Effector caspases cleave and inactivate cellular proteins, which will lead to 
cellular destruction, although they can also activate other caspases.  
Pro-inflammatory caspases (caspase-1, -4, -5, -11, -12, -13 and -14) are 
synthesised as pro-forms with large NH2-terminal pro-domains containing CARD, and 
their main role lies in cytokine maturation rather than apoptotic activity [10, 13, 27].  
  
Figure 1. Structure and classification of the caspase family. (A) Diagrammatic representation of the three 
major groups of caspases: pro-inflammatory (group I), apoptotic initiator (group II), apoptotic executioner 
(group III). (B) Schematic representation of pro-caspase activation. (C) Three-dimensional structure of the 
caspase-3 heterotetramer composed of two heterodimers p17/p12. NH2- and CH2- termini of the small and 
large subunits are indicated. Adapted from [28]. 
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 The caspase zymogens are present in almost every nucleated animal cells and 
become active in response to several internal or external stimuli [7, 29]. Although most 
pro-caspases have a cytosolic location, when apoptosis is activated the caspases can be 
localised in several organelles of the cell, including mitochondria, endoplasmic reticulum 
or microsomal fraction, in order to cleave their substrates [30]. The caspases’ substrates 
are cleaved at a specific Asp residue that must be in the context of tetrapeptide motifs, 
i.e., at least four amino acids contiguous to the cleavage site must be recognised for 
efficient catalysis. In the tetrapeptide motifs, the NH2-terminal residue is designated P4 
and the target Asp is P1. The tetrapeptide motifs recognised by different caspases differ 
significantly, explaining the diversity of their biological functions [10, 12]. So far, 
approximately 400 substrates of mammalian caspases were identified and are gathered at 
the online Caspase Substrate Database Homepage (CASBAH), being most of them 
related to apoptosis [31]. Caspase substrates are usually cleaved at a single site, resulting 
in the loss or change in function, meaning that substrate cleavage by caspases is not only 
specific but also highly efficient [10, 12, 32]. 
 
1.1. Functions 
 Caspases play an essential role in the two principal apoptotic pathways (Box 2), 
contributing to the cell death and to the apoptotic phenotype. They inactivate protective 
pathways and activate downstream reactions, leading to cellular destruction. Caspases 
cleave key structural components of the cytoskeleton, destroy DNA, disrupt the nuclear 
structure, induce the cell to display signals that mark it for phagocytosis and disintegrate 
the cell into apoptotic bodies. Accordingly, the caspase inhibition using synthetic or natural 
inhibitors abolishes apoptosis and a deletion in caspase genes leads to defects in 
apoptosis, revealing a definitive role for caspases in this process [10, 12]. 
 The identification of activated caspases in the absence of cell death led to the idea 
that the apoptotic caspases have other functions beyond the apoptotic context [33]. For 
instance, it was shown that caspase-3 is involved in the differentiation of embryonic, 
hematopoietic and neural stem cells (by facilitating neurogenesis), as well as in 
maturation of dendritic cells [34-36]. Non-apoptotic functions of caspase-9 were also 
described in patients with Alzheimer disease [37], in muscle differentiation [38] and in 
aged olfactory bulb of mice [39]. In addition, caspase-8 is involved in non-apoptotic 
signalling pathways and defects in this caspase are the cause of some autoimmune 
diseases, revealing a significant non-apoptotic role of caspase-8 in the regulation of cell 
migration and in the proliferation of immune cells [40]. Humans with caspase-8 deficiency 
have immunodeficiency caused by alterations in the activation of T- and B-lymphocytes, 
and  natural  killer  cells  [41, 42]. The maintenance  of  genomic integrity and suppression  
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Box 2. Pathways for the induction of apoptosis  
Apoptosis may follow two principal pathways:  
(i) The extrinsic pathway 
is initiated at tumour 
necrosis factor (TNF) 
super family receptors at 
the cell surface or at the 
dependence receptors at 
the cell surface (like 
UNC5A-D and DCC) [23]. 
One example of an 
extrinsic apoptotic 
pathway is the apoptosis 
occurring after the binding 
of the Fas ligand to Fas 
receptors (a member of 
the TNF-R superfamily of 
death receptors) on the 
surface of the target cells. 
After ligand engagement, 
Fas interacts with the 
adaptor molecule FADD 
(Fas-associated death 
domain protein) and pro-caspase-8 is recruited to the “death-inducing signalling complex” (DISC), a 
multiprotein complex that is rapidly assembled at the cytoplasmic portion of the Fas. The death effector 
domain (DED) of pro-caspase-8 associates with the DED of FADD resulting in the activation of caspase-8. 
Caspase-8 is released from the complex in its active form and activates the downstream caspases, including 
caspase-3, -6, and -7, leading to the characteristic morphological changes of apoptosis (Box 1 and [7, 43, 
44]). (ii) The intrinsic pathway can be activated through several stress types, including irradiation, ultraviolet 
light, and cytotoxic drugs, among others [23, 45]. The cascade of events leading to caspase activation initiates 
when the apoptotic signal induces the release of several molecules, including cytochrome c, from the 
mitochondrial intermembrane space into the cytosol. Once in cytosol, cytochrome c binds to the Apoptotic 
Protease-Activating Factor-1 (Apaf-1), and multiple pro-caspase-9 molecules are recruited to the complex. 
This multiprotein complex, named apoptosome, is constituted by seven molecules of each Apaf-1, cytochrome 
c, (d)ATP and pro-caspase-9 [46]. The apoptosome facilitates the trans-processing of caspase-9 zymogens 
via the proximity-induced dimerization mechanism. The active caspase-9 is able to efficiently cleave and 
activate downstream executioner caspases such as caspase-3, which will subsequently cleave many 
important intracellular substrates, leading to apoptotic cell death [7, 43, 44]. Although the two pathways may 
function independently, cross-talk can occur between them at multiple levels. Caspase-8 cleavage of Bid, a 
pro-apoptotic member of the Bcl-2 family (Box 5), leads to the activation of this molecule. The truncated Bid 
translocates to the mitochondria, where it promotes the dimerization of Bax and Bak that form an oligomeric 
pore in the outer mitochondrial membrane allowing the exit of cytochrome c to the cytosol. Other caspases, 
such as caspase-3, as well as other proteases (like Granzyme B) have been shown to cleave and activate 
Bid, meaning that this is not a feature restricted to caspase-8 [47-50]. 
 
Adapted from [51] 
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of necroptosis are also part of the diverse functions of caspase-8 [52, 53].  
 The involvement of pro-inflammatory caspases in cytokine maturation is well 
established and was first recognised for caspase-1 [54-56]. Nevertheless, the processing 
of inflammatory cytokines are no longer the only reported functions of this group of 
caspases. For instance, caspase-1 has been implicated in pyroptosis (Box 3), a new form 
of cell death that is induced in macrophages infected with Salmonella typhimurium [57] 
and surprisingly, is also responsible for processing more than 40 different proteins [58]. 
The wide range of caspase-1 substrates includes the executioner caspase-7 [59] as well 
as glycolytic enzymes, such as GAPDH (glyceraldehyde 3-phosphate dehydrogenase) 
[58]. 
 
Box 3. Pyroptosis 
Pyroptosis [57] is a subroutine of cell death that involves 
the activation of caspase-1 observed in macrophages 
and dendritic cells infected with several classes of 
pathogens [24]. Pyroptosis has been described as a 
powerful mechanism to eliminate intracellular pathogens. 
In this context, caspase-1 mediates host defence 
responses and prevents pathogen replication by inducing 
pyroptotic cell death [60-62]. Morphological features of 
pyroptosis are distinct from the ones of apoptosis and 
include the increase in cell size and loss of plasma-
membrane integrity in cells where the nucleus and the 
mitochondria remain intact. During pyroptosis, the pro-
inflammatory cytokines IL-1β and IL-18 are processed 
and released, and chromosomal DNA is cleaved, 
although in a different pattern from apoptosis [61, 62].                           Adapted from [24] 
 
1.2. Activation and regulation 
 The caspase zymogens become active in response to several internal or external 
stimuli. The proteolytic processing of the pro-enzymes to form the active caspases occurs 
on the carboxyl side of Asp residues, resulting in the removal of the NH2-terminal pro-
domain and the formation of a heterotetramer composed of two large and two small 
subunits with two active sites, that seem to function independently, at opposite ends of 
each molecule (Figure 1) [10, 12]. Exceptions have been reported for DRONC from 
Drosophila melanogaster [63], the mammalian caspase-9 homolog, and sea bass 
caspase-1 (Chapter VI), where cleavage at a glutamate residue may also occur. The fact 
that caspases are activated by proteolytic processing at Asp residues and also cleave 
their substrates at Asp residues, suggests that caspases can auto-activate (by auto-
proteolysis) or can be activated by enzymes with similar specificity.  
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 The activation of caspases requires the formation of a heterotetramer composed 
by the association of two heterodimers of p20/p10 [10, 11, 29, 43]. The initiator caspases 
exist as inactive monomers and are activated by dimerization at specific molecular 
platforms by a process that does not requires the removal of the linker region [10, 11, 29, 
43, 64, 65]. The proximity-induced dimerization mechanism explains the activation 
process of pro-caspase-9 at the apoptosome and pro-caspase-8 at the DISC [64, 65]. In 
response to a death stimulus, these caspases are activated by a mechanism that involves 
the assembly of a molecular platform and the association with a regulatory subunit and, 
subsequently, the recruitment of the initiator pro-caspases through their pro-domains, 
such as DEDs or CARDs. In this complex mechanism, the caspase is suggested to be 
activated through conformational change.  
  
Box 4. Inflammasomes 
The inflammasomes are multiprotein complexes with more than 700 kDa where caspase-1 is activated. The 
assembly of the inflammasomes is initiated upon recognition of several pathogen-associated molecular 
patterns (PAMPs) or damage-associated molecular patterns (DAMPs) by members of the NOD-like receptor 
(NLR) or the HIN-200 receptor families. The apoptosis-associated speck-like protein (ASC), which contains a 
caspase recruitment domain (CARD) and a pyrin domain (PYD), is an essential protein in the inflammasomes. 
The adaptor molecule ASC interacts with the NLR and with caspase-1 through the PYD and CARD, 
respectively. Several types of inflammasomes have been described, according to the receptor that recognises 
the activator molecule. In the case of the inflammasome that starts with NLRP3, which can be activated by 
UV-irradiation, microbial PAMPs or endogenous DAMPs, the PYD of the receptor NLRP3 interacts with the 
PYD of the ASC, which in turn allows the interaction of its CARD with the CARD of caspase-1, leading to its 
activation [24, 66, 67]. As a result of caspase-1 activation, the inflammasomes promote an inflammatory 
response through the activation of the pro-inflammatory cytokines, IL-1β and IL-18, and are involved in the 
induction of pyroptosis (Box 3). The inflammasomes, by inducing immune responses that limit pathogen 
progression, constitute an important intracellular defence mechanism against several pathogens, including 
bacteria, viruses, fungi and 
parasites. Therefore, it is not 
surprising that several successful 
pathogens have developed 
strategies to interfere with the 
activation of the inflammasomes, 
disarming the innate immune 
defences of the hosts [56, 68, 
69]. Besides their central role in 
the innate immune responses, 
recent studies have implicated 
the inflammasomes in metabolic 
diseases and carcinogenesis, as 
well as in the regulation of the intestinal microbial ecology [56, 68, 69].                                           Adapted from [68] 
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The local concentration of the pro-caspase increases and a conformational change is 
induced, producing a microenvironment that allows the pro-caspase to aggregate and 
interact with specific adaptor proteins, like FADD/MORT1 or Apaf-1, leading to activation 
through proximity-induced dimerization [10, 11, 29, 43]. For this reason, initiators pro-
caspase-8 or -9, which possess weak protease activity, when in high concentrations are 
able to cleave other pro-caspase-8/-9 molecules. As for the initiator caspases -8 and -9, 
caspase-1 is also activated by an identical dimerization mechanism in a multiprotein 
complex known as inflammasome (Box 4 and [10, 68]). 
 In contrast to the initiator caspases that exist as inactive monomers, the effector 
caspases exist in the cells as inactive dimers and need to be catalytically cleaved within 
their linker region between the large and small subunit for activation. The proteolytic 
processing and activation of effector caspases is mainly performed by previously activated 
initiator caspases, but also by other proteases that cleave theirs substrates at an aspartic 
acid, such as Granzyme B [70-72]. As a result, the tetrapeptides recognised by the 
initiator caspases normally match the sequences of the cleavage sites separating the 
large and small subunits of the zymogens of the effector caspases [10, 29, 43]. Thereby, 
the effector caspases do not need such a complex mechanism of activation as the initiator 
caspases [10, 11, 29, 43]. Therefore, caspases form a cascade of proteolytic activities in 
which the initiator caspases start the dead effector machinery and the effector caspases 
complete most of the proteolysis of critical substrates that will lead to apoptosis.  
 The accidental activation of a caspase could have a devastating effect and, for that 
reason, the process of activation must be tightly regulated. The regulation of caspases 
occurs at different levels, from gene expression to several steps of the caspase 
production, processing and activity. Upon a cell death signal, the activation of the 
apoptotic program is regulated by an accurate balance between the pro-apoptotic and 
anti-apoptotic mechanisms, in which the Bcl-2 family members (Box 5) play a crucial role 
[73]. The mitochondrial outer membrane permeabilization (MOMP) is an important 
mechanism that allows the release of several regulatory proteins from the intermembrane 
space of mitochondria, and is ensured by the pro-apoptotic members of Bcl-2 family, Bax 
and Bak (Box 5). One example of a released pro-apoptotic molecule is the apoptosis-
inducing factor (AIF) that was reported to induce a caspase independent apoptosis-like 
cell death [74]. Under different apoptosis-inducing conditions, the mature AIF protein, 
normally localised in the mitochondrial intermembrane space, translocates through the 
outer mitochondrial membrane into the cytosol and into the nucleus, inducing nuclear 
chromatin condensation, as well as large scale DNA fragmentation [74]. Other examples 
of pro-apoptotic molecules that are released from the mitochondria are the Smac/Diablo, 
the serine protease Omi/Hrt2 and the endonuclease G [74-76]. The protein Smac/Diablo 
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is normally localised at the mitochondrial intermembrane space and upon an apoptotic 
stimuli is released to the cytosol where it can sequester and neutralise the anti-apoptotic 
effect of the inhibitors of apoptosis proteins (IAPs) allowing the activation of caspases to 
carry on [47, 77].  
 The extrinsic and intrinsic apoptotic pathways can be negatively regulated by IAPs, 
that act as competitive inhibitors that bind to the active site of caspases and thus, regulate 
their activation and activity [47, 78]. The most studied member of the IAP family is XIAP 
(X-chromosome-encoded inhibitor of apoptosis proteins) that contains three BIR 
(Baculoviral IAP Repeat) domains at the NH2-terminus. The BIR1 and 2 domains are 
involved in the inhibition of caspase-3 and -7 while caspase-9 activity is inhibited by the 
BIR3 domain [47, 79]. 
 The most well characterised inhibitors of the extrinsic pathway are c-FLIPs (cellular 
FLICE inhibitory proteins). The c-FLIP family was originated by tandem duplication of 
caspase-8 and -10 genes having two DEDs as these caspases and thus, compete with 
the ligation of caspase-8 to the DEDs of the death receptors [80]. Therefore, the inhibition 
of caspase-8 activation by c-FLIPs results from a defective recruitment of caspase-8 to 
the DISC [81-83]. Although the inhibitory role of c-FLIPs has been widely documented, 
one of the isoforms, FLIPEL, has shown to induce survival or death depending on its 
concentration levels [84]. 
 Along with the regulation through different protein factors, the caspase activity can 
also be regulated by the presence of isoforms, which are products that derive from the 
full-length form by alternative splicing. For instance, one mechanism of caspase-3 
regulation relies on caspase-3s, a short isoform of caspase-3 that is originated by 
alternative splicing [85]. This short version of caspase-3 lost the exon six, resulting in a 
complete absence of the short subunit and also of the 95 amino acids at the C-terminal of 
the large subunit, including the active centre. Caspase-3s was found to be expressed in 
several human tissues and has approximately 20 kDa. Caspase-3s competes with 
caspase-3 activation at the apoptosome complex and consequently, the formation of an 
efficient active caspase-3 is affected. When both caspases are expressed together in cells 
that received an apoptotic stimulus, the cleavage of PARP1 and the DNA fragmentation is 
prevented and therefore, the apoptotic process is compromised [85]. 
 Human caspase-9 also has alternative variants that have an inhibitory role in the 
activation of caspase-9 [86, 87]. Caspase-9b is a small variant of caspase-9 traduced 
from a cDNA missing exons 3, 4, 5 and 6. This results in a protein that has the pro-domain 
and the small subunit intact but lacks most of the large subunit, including the catalytic site. 
In vitro binding assays demonstrated that caspase-9b inhibits caspase-9 activation by 
competing to the CARD-CARD interactions with Apaf-1-caspase-9 and thus, by 
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preventing the formation of a functional apoptosome [86, 87]. A caspase-9 isoform, Casp-
9-Carboxyl-terminal divergent (CTD), was also identified in rat and CTD was shown to 
have an alternative peptide sequence replacing the C-terminal of the full-length caspase-
9. Like the previous discussed caspase isoforms, CTD is expressed in several tissues and 
was implicated in the regulation of cell death, since it interferes with the activation of 
caspase-9 [88].  
Another important mechanism for regulating the caspase-8 is the multiple splicing 
of caspase-8 gene. Caspase-8 co-expressed with caspase-8 isoforms possessing 
incomplete caspase regions resulted in decreased cell death [89, 90]. For example, 
caspase-8L, modulates the caspase-8 activity by the homotypic binding to FADD. This 
isoform exerts its dominant effect by preventing the coupling of pro-caspases-8 and 
subsequent apoptosis by the receptor pathway [91].  
In human, four additional isoforms of caspase-1 were identified: the isoform β and 
γ, lacking part of the pro-domain, and the isoforms δ and ε, where most of the pro-domain 
and the region containing the active site have been deleted [92]. Like the caspase 
isoforms described above, these isoforms may have a regulatory role in the activation 
process of caspase-1. For instance, in the isoform ε most of the pro-domain and all the 
p20 subunit were deleted, meaning that this isoform has only the p10 subunit with 19 
different amino acids in the NH2-terminus. This incomplete p10 prevents the formation of 
an active tetramer by competing with the p10 subunit of caspase-1 [92].  
 
2. Fish caspases 
 A high conservation at the molecular and functional levels has been described 
between the players of the apoptotic machinery in invertebrates (Caenorhabditis elegans 
and Drosophila) and mammals [93, 94]. However, fish represent an excellent and 
advantageous model for the study of vertebrate development and disease [95-98], 
bridging the gap between the C. elegans/Drosophila and mouse/human models [99]. 
Moreover, contrary to C. elegans and Drosophila, fish can be used for studying the 
development and function of vertebrate-specific organs and have a fully developed 
immune system similar to that of mammals [100]. Despite the increasing interest in 
caspases and their evolutionarily conserved function, until the beginning of the 21st 
century, the information on caspases was limited to mammals (human and mouse), 
Drosophila, C. elegans and to a few reports on chicken [101], frog [102], and a few fish 
species [103-105]. Since then, the number of sequenced caspases from different species 
has been increasing. At the moment, 11 and 10 caspase genes were identified in the 
human and mouse genomes, respectively. In humans, the 11 genes encode caspase-1,   
-2, -3, -4, -5, -6, -7, -8, -9, -10 and -14. The mouse caspases are functional orthologs of  
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Box 5. Bcl-2 family 
Bcl-2 family members have been extensively studied in mammalian systems, mainly due to their importance 
as key regulators of apoptosis, playing a central role in some pathological conditions, including cancer, 
neurodegenerative disorders and autoimmune diseases [45, 73, 106]. Briefly, Bcl-2 family members include 
proteins with sequence and structural similarity in the so-called Bcl-2 homology (BH1 to BH4) domains. Bcl-2 
proteins regulate the response to diverse cytotoxic conditions such as UV- and γ-irradiation, anti-neoplastic 
drugs, virus and bacteria, but normally have limited impact on the signals induced by the death receptors of 
the TNF family [107]. Bcl-2 members can be anti-apoptotic (like Bcl-2 and Bcl-xL) or pro-apoptotic (such as 
Bad, Bik, Bid, Bim). The anti-apoptotic members are mainly characterised by containing three to four BH 
domains and for inducing cell survival by sequestering/inhibiting pro-apoptotic scaffold or adaptor proteins and 
pro-apoptotic members needed for activation of caspases, and/or by maintaining organelle integrity [45, 73, 
108]. Pro-apoptotic members can be subdivided into BH3-only proteins (“activators” and “de-
repressors/facilitators”), which, as the name stands for, only contain the third BH domain (Bid, Bim, Bad) [109-
111], or multidomain pro-apoptotic proteins (Bax and Bak). These share a high degree of structural similarity 
with pro-survival Bcl-2 family members, containing two to three BH domains, and all having the BH3 domain 
responsible for the pro-apoptotic activity [76, 108]. At least in some instances, cell death can be prevented at 
the mitochondrial level by anti-apoptotic Bcl-2 members which, depending on their relative abundance, can 
inhibit the release of apoptogenic molecules into the cytosol [108]. In addition, Bcl-2 family members are also 
involved in the regulation of several types of pro-apoptotic signals that are generated in organelles other than 
mitochondria, such as nucleus, endoplasmic reticulum and lysosomes [45]. 
That fish have functionally conserved Bcl-2 family members, similar to the ones found in mammals, has been 
shown by several lines of evidence. Fish have, in their genomes, homologs of virtually all mammalian Bcl-2 
family members regulated by similar transcriptional and posttranslational mechanisms. Most of the data 
related with the Bcl-2 family members of fish refer to zebrafish although their presence in other fish species 
was also reported such as Bax and Bcl-XL in trout [112], Bcl-2 in gudgeon [113], and Bcl-2 and mlc-1 in carp 
[114]. Bcl-2 family members in other fish species can also be found in non-redundant and EST (Expressed 
Sequence Tags) public databases as well as genomic sequence databases (Table 2 in Annex 1). Several fish 
Bcl-2 family genes have two copies (Table 2 in Annex 1 and [115]) resulting from the early whole-genome 
duplication in the teleost lineage after the divergence from tetrapods about 450 million years ago [116-118].  
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human caspases and maintain the same names with the exception of caspase-11 and -12 
that are functional orthologs of caspase-4 and -5, respectively. The other exception is 
caspase-10 which is absent in the mouse genome [6, 11]. 
 
2.1. Fish apoptotic initiator caspases 
 Caspase-8 (also known as FLICE/MACH1/Mch5) is an essential component of the 
extrinsic/death-receptor pathway (Box 2 and [23]). The identification and characterisation 
of caspase-8 from medaka, stickleback, zebrafish and sea bass (Chapter III and [119-
121]) have recently been reported. At the genomic level, whereas zebrafish caspase-8 
genes show a similar structure as their mammalian equivalents, being organised in 10 
exons and 9 introns with coincident splice junctions sites [119, 122], the sea bass, 
medaka and stickleback caspase-8 genes present 12 exons and 11 introns, with the 
additional exons located at the first death effector and protease domains (Chapter III and 
[120]). Although results from Southern blot analysis suggested that the sea bass caspase-
8 gene is a single copy gene (Chapter III), the caspase-8 gene is apparently duplicated in 
the genome of several species of fish (Table 2 in Annex 1). Chromosome mapping 
showed that the chromosomal segment around the zebrafish, medaka, fugu and 
stickleback caspase-8 genes has an organisation syntenic with that of other vertebrates 
[119, 120]. Fish caspase-8 molecules revealed about 35% identity and 55% similarity to 
the human counterpart, which together with the above data supports that fish caspase-8 
genes are orthologs of mammalian caspase-8. As their amphibian and mammalian 
homologs, fish caspase-8 possess two DEDs at their NH2-terminal pro-domains, and a 
carboxyl-terminal catalytic domain (CASc) including conserved amino acids essential for 
catalytic activity and the characteristic pentapeptide active site QACQG (QACRG in 
zebrafish caspase-8b) (Chapter III and [119, 120]). That zebrafish caspase-8 associates 
with the adaptor molecule FADD through homophilic DED interactions was shown by 
detecting zebrafish caspase-8 and human FADD in immunoprecipitates of HEK293T cells 
co-expressing HA-tagged human FADD with Flag-tagged zebrafish caspase-8 [119]. 
Additionally, exogenous expression of zebrafish caspase-8 in caspase-8-deficient mouse 
embryonic fibroblast (MEF) cells triggered cell death with or without ligation of Fas, the 
former showing an increased sensitivity, with 80% of the transfectants dying following Fas 
ligation. This indicates that zebrafish caspase-8 directly transmits apoptotic signals via 
Fas to downstream molecules, including, as shown in zebrafish caspase-8-expressing 
HeLa cells, caspase-3; the same holds true for TNFα induced-cell death [119]. Similarly, 
exogenous expression of medaka caspase-8 induced apoptotic death in transfected HeLa 
cells, but apoptotic death was inhibited by either zVAD-fmk, the anti-apoptotic cowpox 
virus serpin cytokine response modifier A (CrmA) [123], or the pan-caspase inhibitor p35 
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[120]. Furthermore, co-injection of zebrafish FLIP, or CrmA, reduced zebrafish caspase-
8a-mediated embryonic mortality, confirming that caspase-8 functions similarly in 
zebrafish and mammals [124]. The long splice form of the extrinsic pathway inhibitor 
cellular FLIP (cFLIP) is a key regulator of the extrinsic pathway of caspase-8 activation, 
inhibiting the recruitment and activation of caspase-8 by death receptors [78, 82]. Like 
mammalian FLIP, which contains two DEDs that interact with the DED in FADD, zebrafish 
FLIP is structurally similar to caspase-8 and -10 and lacks an active-site cysteine [124]. 
Inhibition of caspase-8-mediated apoptosis in early zebrafish embryos has been also 
shown to occur through interactions of Yaf2 with the DED of caspase-8, with implications 
on cell survival during zebrafish embryogenesis [121]. Yaf2 is a member of the Rybp/Yaf2 
protein family, with Rybp (also known as DEDAF) being described in mammals as 
interacting with DED-containing proteins, including FADD, caspase-8, caspase-10, and 
DEDD, for promoting Rybp pro-apoptotic activity [125]. Finally, induction of extensive 
apoptosis in zebrafish embryos injected with zebrafish caspase-8a mRNAs [124] as well 
as detection of caspase-8 transcription by RT-PCR in both maternal and zygotic 
transcripts during zebrafish embryonic development, with ubiquitous expression in whole 
embryos [119], suggested that caspase-8 plays an important role during embryonic 
development of fish embryos similarly to mammalian/amphibian embryos. Moreover, in 
sea bass treated with Photobacterium damselae ssp. piscicida (Phdp) culture 
supernatants (known to induce apoptosis of sea bass macrophages and neutrophils), the 
expression levels of caspase-8 in the spleens were increased (Chapter III). The 
involvement of sea bass caspase-8 in the Phdp infection model is further supported by the 
detection of caspase-8 activity in sea bass peritoneal phagocytes treated with 
recombinant AIP56 [126]. The above data confirm that, like its mammalian homolog [90, 
127], fish caspase-8 is an initiator caspase recruited to the DISC via binding to the 
adaptor protein FADD, transmitting apoptotic signals from death receptors to downstream 
effector caspases; it can also mediate cross-talk between the extrinsic and intrinsic 
apoptotic pathways, since fish Bid sequences reveal conservation of the caspase-8 
cleavage site. 
 Caspase-10, similarly to caspase-8, contains two DEDs and a CASc, and is 
involved in the Fas ligand-mediated cell death pathway [10, 47]. Both caspases are not 
clearly distinguished since, for instance, the difference in the activation process is not well 
studied in detail [128]. Recent studies demonstrated that caspase-10 inhibition prevents 
apoptosis mediated by the TRAIL-R2 receptor in human immune cells, proving that 
caspase-10 has an important role in apoptosis mediated by this receptor [129]. Despite 
caspase-10-like genes with high degree of similarity to human caspase-10 have been 
reported for fish and can be found in the databases (Table 2 in Annex 1), the only 
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characterisation of a fish caspase-10 belongs to the Japanese flounder [130]. The gene 
has 6.6 kb and is organised in 11 exons and 10 introns similar to the human caspase-10. 
Additionally, the sequence conserves characteristic features such as the DEDs, the large 
and small subunits and the pentapeptide active site (QACQG), suggesting that it may 
have a similar function as the human caspase-10. Although the sequence of Japanese 
flounder caspase-10 revealed 35.3% and 32.6% similarity to human caspase-8 and -10, 
respectively, the phylogenetic tree clusters the fish caspase-10 with other caspase-10 
sequences. The Japanese flounder caspase-10 mRNA was found to be expressed in 
several tissues and an over-expression in the cell line HINAE resulted in the induction of 
apoptosis [130]. Since, in addition to caspase-8 and caspase-10, other components 
essential for forming the DISC, as well as death ligands and the BH3-only member Bid, 
have been identified in fish (Annex 1), these data strongly point to the existence of a 
structural and functional conserved extrinsic/death receptor apoptotic pathway in 
vertebrates. 
 Although caspase-2 was one of the first caspases to be discovered and has been 
implicated in the regulation of cell cycle progression [131], its role in apoptosis remains a 
matter of considerable debate [131]. Caspase-2 genes have been identified in fish (Table 
2 in Annex 1 and [99, 124]), but no detailed structural and functional characterisation of a 
fish caspase-2 has been reported so far. The fact that fish caspase-2 gene presents a 
conserved synteny with the human ortholog and that fish caspase-2 contains a CARD in 
its pro-domain (Figure 2), suggests that this protease plays a similar role in the apoptotic 
process of fish and mammals. 
 Caspase-9 (also known as ICE-LAP6/MCH-6/Apaf-3) is a member of the CED-3 
subfamily, bearing high similarity to caspase-3, and is a key component of the 
intrinsic/mitochondrial death-pathway (Box 2 and [23, 132, 133]). Caspase-9 genes have 
been identified in some species of fish (Table 2 in Annex 1), and the primary structures of 
sea bass (Chapter IV), and large yellow croaker [134] caspase-9 were characterised. 
BLAST analysis revealed homology between fish caspase-9 and their vertebrate 
equivalents, and, as expected, fish caspase-9 presented higher similarity (>90%) and 
identity (>84%) with other fish counterparts than with that of non-fish vertebrates (46-48% 
identity and 59-64% similarity). Sea bass and large yellow croacker caspase-9 genes are 
organised in 10 exons and 9 introns, which, when compared with the human homolog, 
represents an extra exon located in the predicted pro-domain (Chapter IV and [134]). 
Southern blot analysis of sea bass genomic DNA suggested that, in fish, caspase-9 gene 
exists as a single copy gene, an hypothesis that is supported by the fact that only a single 
caspase-9 gene has been identified in other fish species (Table 2 in Annex 1 and [124]). 
Additionally, fish caspase-9 genes likely preserve a conserved synteny with the human 
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ortholog, as indicated by the reported analysis of the zebrafish caspase-9 [124]. 
Moreover, fish caspase-9 conserves characteristic caspase-9 features (Figure 2) [10] 
such as a CARD in the NH2-terminal pro-domain, a large (p20) and small (p10) subunits, 
a 
caspase family signature, and all important catalytic residues, including the active site 
pentapeptide QACGG (Table 2 in Annex 1). The presence of CARD in fish caspase-9 is 
relevant, taking into account that fish apoptotic protease-activating factor 1 (Apaf-1) was 
identified and contains CARD, a nucleotide-binding oligomerization domain (NO) and WD-
40 repeats (Table 2 in Annex 1 and [99]). This suggests that, like mammals [135], fish 
might regulate caspase-9 activity in an Apaf-1/cytochrome c-dependent manner within the 
apoptosome context [75, 136]. In addition, a homolog of Nod1, an Apaf-1-like molecule 
that regulates apoptosis and NF-κB activation [137, 138], was found in zebrafish [99]. As 
with the mammalian equivalents [47, 78, 132, 139], further regulation of fish caspase-9 
may be also achieved through inhibition by IAPs, as both IAP and XIAP homologs have 
been identified in fish (Table 2 in Annex 1 and [99, 124]). Structural studies suggest that 
the NH2-terminal BIR2 linker region of XIAP occupies the catalytic site in active caspase-3 
and -7, whereas the XIAP BIR3 domain is required for inhibiting caspase-9 [47, 78, 132, 
139]. 
 
 
Figure 2. Fish apoptotic and inflammatory caspases. Diagrammatic representation of the domain architecture 
of the executioner and initiator apoptotic caspases, pro-inflammatory caspase-1 and putative apoptotic/pro-
inflammatory caspase pro-enzymes of fish.  
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The identification of Smac/DIABLO homologs and several serine proteases highly similar 
to HtrA2/Omi in fish (Table 2 in Annex 1) also indicates that the inhibitory effect of IAPs 
may be neutralised in a similar way as in mammals, i.e., during apoptotic signalling, 
Smac/DIABLO and HtrA2 are released from the mitochondria into the cytoplasm where 
they bind to XIAP and prevent its inhibitory activity [47, 78, 132, 139]. Indications of 
caspase-9 function and involvement in apoptosis in fish were obtained by detection of 
caspase-9 transcription by RT-PCR in head kidney of sea bass infected with the 
apoptotic-inducing bacteria Phdp. The increased expression of caspase-9 correlated with 
the presence of apoptotic cells and putative caspase-9 activity in the head kidney, the 
latest detected by a luminescence assay using a proluminescent substrate containing the 
caspase-9 specific cleavage tetrapeptide LEHD (Chapter IV). Recent studies in large 
yellow croaker suggested that the intrinsic apoptotic pathway might be implicated in the 
immune response in spleens and kidneys stimulated with poly(I:C), since the levels of 
caspase-9 expression and the enzyme activity increase in these conditions [134]. Taken 
together, the above data represent strong evidence that apoptotic processes involving 
caspase-9 as well as the mechanisms of caspase-9 regulation are evolutionarily 
conserved among vertebrates, pointing to the existence of a conserved functional intrinsic 
apoptotic pathway in vertebrates.  
 
2.2. Fish apoptotic executioner caspases 
 Caspase-3 is the main downstream effector caspase that, once activated by 
initiator caspases, except caspase-2 [10, 132, 140], cleaves the majority of the cellular 
substrates in apoptosing cells [10, 132, 140]. Caspase-3 is the most well characterised 
caspase in fish, including zebrafish [103, 141], salmon [142], sea bass (Chapter V) and 
large yellow croaker [143]. BLAST search revealed a close relation between fish caspase-
3 and the caspase-3 molecules of other vertebrates, which is supported by the relatively 
high percentage of amino acid identities (50-80%) (Chapter V and [103]). Fish caspase-3 
presents smaller introns than the human equivalent, and presents a 6 exon/5 intron (7 
exon/6 intron in zebrafish) structure, while the human gene has an 8 exon/7 intron 
structure. However, they all conserve an identical gene organization within the coding 
region. Although Southern blotting has suggested that sea bass caspase-3 is a single 
copy gene (Chapter V), it is likely that it is present in all fish genomes as a duplicate gene, 
as two caspase-3 genes have been identified in other fish species (Table 2 in Annex 1). 
Whether the duplicates have acquired distinct spatiotemporal functions requires further 
investigation. As their mammalian homologs, fish caspase-3 present a short NH2-terminal 
pro-domain and a catalytic domain containing both caspase p20 and p10 subunits, a 
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caspase family signature and all important catalytic residues, including the characteristic 
pentapeptide active-site QACRG (Figure 2) (Chapter V and [103, 142, 143]). The 
apoptotic function of fish caspase-3 has been widely demonstrated. Thus, high proteolytic 
activity towards the mammalian caspase-3 and -7 substrate Ac-DEVD-MCA was reported 
for the recombinant zebrafish caspase-3, whereas it had low activity against the caspase-
1, caspase-6/ -8, and caspase-9 substrates (Ac-YVAD-MCA, Ac-IETD-MCA and Ac-
LEHD-MCA, respectively), indicating a similar substrate specificity to that of mammalian 
caspase-3 [103]. Moreover, overexpression of the zebrafish caspase-3 in cultured fish 
cells and zebrafish embryos induced apoptosis that could be repressed by the inhibitor of 
mammalian caspase-3 Z-DEVD-FMK [103]. Zebrafish embryos microinjected with a 
zebrafish caspase-3 expression vector also had high Ac-DEVD-MCA-hydrolysing activity. 
In the same study, Yabu et al also showed that the expression of the zebrafish caspase-3 
gene was regulated in both a tissue- and stage-specific manner, with caspase-3 mRNA 
from maternal origin being present in early embryogenesis and after gastrulation by 
zygotic genome activation, especially in the pectoral fin bud, optic vesicle and hindbrain 
[103]. Finally, an increase of caspase-3 expression was observed in the head kidney of 
sea bass infected with the apoptotic-inducing bacteria Phdp, which was accompanied by 
the occurrence, in that organ, of cells with apoptotic morphology and activated caspase-3 
(Chapter V). In the large yellow croaker it was shown that caspase-3 expression and 
activity are increased in spleen and kidney stimulated with poly(I:C) [134, 143]. 
 Caspase-7 is highly similar to caspase-3 (Figure 2) and has similar substrate 
specificity [10, 132]. However, at least for apoptosis induced via the intrinsic pathway, a 
combined function of caspase-3 and -7 is apparently required for cell death execution [10, 
132, 144]. Caspase-7 has been identified in several fish species as a duplicated gene 
(Table 2 in Annex 1) and its primary structure has been recently characterised in salmon 
[142]. The caspase-7 gene from salmon is organised in a 5 exon/4 intron structure, 
differing from the mouse and human counterparts, which have a 6 exon/5 intron structure 
[142]. Caspase-7 mRNA was exclusively detected by whole-mount in situ hybridization in 
the lens of salmon embryos, while caspase-3b, caspase-6a and -6b were expressed in 
multiple organs of heat-stressed and control salmon embryos. Moreover, cell death 
induced in heat-stressed salmon embryos could be correlated with the expression of 
caspase-7, as well as caspase-6 and -3, in a similar way as in mouse embryos [142].  
 Although structurally similar to caspase-3 and -7, caspase-6 (Figure 2) has a 
somewhat different substrate specificity, its optimal substrate being VEHD rather than 
DEVD, the preferred caspase-3 and -7 substrate [145]. Caspase-6 was demonstrated to 
have an important role in neurodegenerative diseases, such as Huntington and Alzheimer 
diseases, through the involvement in neuronal degeneration and death [146]. In fish, it has 
 
Chapter I - Introduction 
 
20 
 
been characterised in trout [104] and salmon [142], being identified as a duplicate [142] or 
even triplicate [124] gene (Table 2 in Annex 1). As caspase-3 and -7, fish caspase-6a and 
-6b have a relatively short NH2-terminal pro-domain followed by a catalytic C-terminal 
domain comprising the large and small subunits, the caspase family signature as well as 
the amino acids involved in catalysis, including the QACRG catalytic site, and those 
forming the P1 carboxylate binding pocket. Caspase-6a and -6b share high identity (98% 
amino acid identity between salmon caspase-6a and -6b) as well as high identity with 
other vertebrate counterparts (>60% amino acid identity). At genomic level, salmon 
caspase-6a presents a 7 exon/6 intron organization, as its human homolog, whereas the 
insertion of an intron within the first exon generated an additional exon in the caspase-6b 
gene, similar to the chicken caspase-6 gene [142]. In human caspase-6, intron 3 is 
involved in activation by binding of the pro-apoptotic transcription factor p53 [147]. 
However, as hypothesised by Takle et al [142] for salmon, the different genomic structure 
of caspase-6a and -6b may cause different regulation of the two genes that may be worth 
investigating. RT-PCR analysis revealed that the trout caspase-6 gene is expressed in 
brain, blood, gill, liver, head kidney and spleen [104]. In salmon, caspase-6a and -6b were 
also expressed in multiple tissues of heat-exposed and control embryos, although cardiac 
expression of caspase-6a and -6b was only observed in heart of the heat-stressed 
embryos, with an apparent correlation with cell death [142]. Trout caspase-6 expression in 
head kidney leukocytes could be specifically increased by addition of LPS, although only 
in the presence of and following a pre-incubation with cortisol [104]. This effect was 
mediated by glucocorticoid receptors, as incubation with the glucocorticoid receptor 
blocker RU486 abrogated the expression of caspase-6 in LPS-stimulated trout leukocytes. 
Moreover, a marked up-regulation of caspase-6 expression in the trout head kidney was 
observed upon in vivo induction of confinement stress. Although both glucocorticoids and 
stress are regarded as inducers of apoptosis in fish [148, 149], no correlation of the 
observed induction of caspase-6 with cell death was reported by Laing et al [104]. The 
above data clearly indicate that fish possess a caspase cascade, similar to that 
characterised in mammals.  
 
2.3. Fish putative apoptotic caspases 
 A caspase-8-like gene, showing high similarity to human and other vertebrate 
caspase-8 and caspase-10 sequences, but possessing a CARD at their NH2-terminal pro-
domains instead of DEDs (and, therefore, tentatively named card-caspase-8), has been 
reported in fish (Figure 2) [105, 119, 120]. The card-caspase-8 is not a third caspase-8/-
10 gene as the one identified in the frog and chicken genomes; instead, it apparently 
results from replacement of its DED by a CARD upon a tandem duplication of the 
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ancestral caspase-8 gene over the course of evolution [119, 120]. In addition to the CARD 
in its pro-domain, card-caspase-8 contains the caspase family signature, the active 
catalytic site, and the large (p20) and small (p10) subunits at the CASc. Moreover, card-
caspase-8 exhibits pro-apoptotic activity [105, 120]. However, it would be interesting to 
find out whether fish card-caspase-8 is activated by interacting with death receptors via a 
CARD-containing adapter molecule such as RAIDD or by recruitment to large multiprotein 
complexes (as caspase-2) [10, 131, 132], or by heterotypic interaction (DED-CARD) with 
FADD. Other caspases mostly homologous to mammalian caspase-8 (zebrafish caspase-
Xa and -Xb), but containing a QACRG active site and lacking obvious NH2-terminal DEDs 
(Figure 2), have also been reported (Table 2 in Annex 1 and [142]).  
 
2.4. Fish inflammatory caspases 
 Caspase-1, also known as ICE (interleukin-1β converting enzyme), is an 
inflammatory caspase that normally exists in the cytoplasm and is involved in 
inflammatory processes and in pyroptosis (Box 3) [68, 150]. As previously mentioned, 
caspase-1 was the first cysteine protease of the caspase family to be identified and it was 
also the first in which the three-dimensional structure has been solved, revealing that 
active caspases are heterotetramers originated from the inactive zymogens [151, 152]. 
The first caspase-1 homologue identified in fish was the sea bass caspase-1 (Chapter VI) 
followed by the caspase-1 of sea bream [153]. Both fish caspase-1 retain the CARD in the 
NH2-terminal pro-domain and the caspase catalytic domain as their mammalian 
counterpart (Chapter VI and [153]), indicating that a strikingly conserved structure has 
been kept throughout evolution. In addition, the sea bass  recombinant caspase-1 
(Chapter VI) is auto-catalytically converted in vitro into two active heterodimeric 
complexes consisting of p10 paired either with p24 or p20 as described for human 
caspase-1 [3, 154-156]. Similarly to what has been described for human caspase-1, 
alternative splicing isoforms were also found in sea bass, all containing the pro- and p20 
domains, including the fully conserved active site QACRG sequence. The differences 
introduced by the alternative splicing events in the sea bass caspase-1 isoforms are all 
located downstream from the active site (Chapter VI), contrary to some of the human 
isoforms [92]. A regulatory role in the activation of caspase-1 have been described for 
proteins containing CARD, such as COP, INCA, ICEBERG and caspase-12, that compete 
through CARD-CARD interactions for the activation of caspase-1 at the inflammasome 
complex [67]. All the sea bass caspase-1 isoforms kept the CARD at the pro-domain and 
thereby could play a role in the regulation of the inflammatory response. The gilthead sea 
bream caspase-1 is constitutively expressed in some immune tissues and the use of a 
caspase-1 specific inhibitor reduces the endogenous caspase-1 activity in the sea bream 
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fibroblast cell line SAF-1 and in primary leukocytes [153]. Additionally, it was reported that 
processing of IL-1β by a gilthead sea bream fibroblast cell line is abrogated by a specific 
caspase-1 inhibitor [157]. However, until recently, the recognition site for caspase-1 
processing was missing in the IL-1β molecules reported so far in non-mammalian 
vertebrates, including fish, and the ability of non-mammalian inflammatory caspases to 
process IL-1β has been a matter of debate. In the present thesis (Chapter VI) it was 
shown that sea bass caspase-1 cleaves sea bass IL-1β at the aspartate residue 100, 
which is absolutely conserved in all IL-1β sequences reported so far (Figure S3 in Chapter 
VI). This could suggest that this aspartate residue would be the non-mammalian caspase-
1 cleavage site. However, analysis of the in vitro cleavage of avian IL-1β using human and 
sea bass caspase-1 suggests that avian IL-1β is cleaved at aspartate residue 80 present 
in a IL-1β stretch where aspartates are also well conserved in most of the IL-1β 
sequences reported so far (Chapter VI). Thus, it is very likely that IL-1β cleavage is a 
class-specific, or perhaps even a species-specific event, and that mammalian IL-1βs have 
acquired a specific caspase-1 cleavage site during phylogeny.  
 Two pyrin domain-containing caspases (Figure 2), caspy and caspy2, as well as 
the zebrafish ortholog of apoptosis-associated speck-like protein containing CARD (ASC), 
were also identified in zebrafish [158]. Whether these caspase molecules play initiator or 
executioner roles in apoptosis is not clear, although the presence of long pro-domains 
and, at least for caspy, the need for oligomerization for its activity, mostly resemble 
initiator caspases. Both caspy and caspy2 contain long NH2-terminal pyrin domains [159] 
and a C-terminal caspase catalytic domain, the latest including conserved amino acids 
residues essential for proteolytic catalysis, and residues essential for interaction with 
critical core residues of substrates, as well as the pentapeptide active site QACRG. 
Whereas the NH2-terminal pyrin domain of caspy and caspy2 were most homologous to 
that present in zebrafish ASC (87% similarity) and to that of human pyrin-domain 
containing Nod-family protein Cryopyrin/PYPAF1 (46% similarity), respectively, the 
catalytic domains shared closer similarity with that of human caspase-1 and -5, 
respectively [158]. Additionally, the pyrin domain of caspy2 exhibits homology not only to 
pyrin domains but also to the CARDs of Xenopus caspase-1 (49% similarity) and bovine 
caspase-13 (45% similarity) [158]. As its mammalian counterparts, zebrafish ASC is 
composed of an NH2-terminal pyrin domain linked to a C-terminal CARD [158]. 
Functionally, both caspy and caspy2 induced apoptosis when transfected into mammalian 
cells, an effect attenuated by p35 and inhibited by zVAD-fmk, whereas only caspy was 
inhibited by the human caspase-1 inhibitor CrmA. Moreover, caspy and caspy2 
preferentially cleave the caspase-1 substrate AcYVAD-AMC or the caspase-5 substrate 
AcWEHD-AFC, respectively [158], suggesting that both are active enzymes with different 
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substrate specificities. Finally, co-immunoprecipitation and expression assays showed 
that only caspy interacts with zebrafish ASC through a homophilic pyrin-pyrin domain 
interaction, involving the same speck [158]. However, proteolytic processing of caspy and 
induction of caspy-dependent apoptosis can only be achieved by enforced oligomerization 
of zebrafish ASC, which is presumably induced through an interaction between the C-
terminal CARD of zebrafish ASC and a putative upstream regulator yet to be identified, 
therefore indicating that ASC is an adaptor molecule [158]. Finally, morpholino antisense 
oligonucleotide-based knockdown of caspy in zebrafish embryos was shown to affect 
development of the jaw and posterior pharyngeal arches with no other abnormalities 
identified in any other part of the body, suggesting that caspy is involved in the execution 
of a program of neural crest cell death required for proper developmental and assembly of 
cartilage [158]. However, it cannot be ruled out that caspy is involved in processing the 
zebrafish IL-1/IL-18 and/or another factor that is required for normal development of 
pharyngeal arch cartilages [158]. So far, the mammalian caspases that play similar roles 
to those played by caspy and caspy2 in fish have not been identified. 
 As a concluding remark, there is compelling evidence that fish do contain 
functional homologs of virtually all members involved in the apoptotic machinery (Table 2 
in Annex 1), making fish excellent models for studying apoptosis-related genetic or 
infectious disorders as well as for drug development. 
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Project Aims 
 
 Over the years, the idea that caspases are important proteins, playing a relevant 
role in inflammation and apoptosis, kept the attention of the scientific community. 
Additionally, recent discoveries attributed to caspases several non-apoptotic functions 
and, consequently, highlighted the significance of caspases and the interest in this 
cysteine protease family. In mammals, the structural features of caspases, along with their 
activation and regulation mechanisms are widely understood. However, novel interactions 
of caspases with other proteins and new aspects of their regulation and participation in 
different acting fields are constantly being discovered, raising unprecedented questions 
and making this a very challenging and fascinating area of research.  
 As reviewed in the introduction section, fish possess caspases and many studies 
point to an evolutionary conserved regulation of caspases and to the existence, in fish, of 
apoptotic and inflammatory processes similar to the ones described in mammals. 
Nevertheless, when the work for this thesis started, the knowledge about fish caspases 
was still very insipient, with only few fish caspases known and characterised. This work 
was developed at the Fish Immunology and Vaccinology group of the IBMC that, during 
the last years, has been using sea bass to study the Photobacterium damselae ssp. 
piscicida pathogenicity mechanism as an example of a bacterial infection where the 
pathogen subverts the apoptotic and pro-inflammatory machineries of the host. This thesis 
was developed in this context, aiming at cloning, sequencing and genetically characterise 
sea bass caspases representing all functional classes. Therefore, the main objectives of 
the present thesis were: 
• To clone, sequence and genetically characterise sea bass caspases 
representing all functional classes, including the apoptogenic caspase-8, -9 and -3, as 
well as the pro-inflammatory caspase-1. 
• To use the information obtained from the above studies to follow the 
involvement of those caspases in physiological and/or immunogenic/pathological 
processes at genomic and proteomic level.  
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Abstract 
IL-1β is the most studied pro-inflammatory cytokine, playing a central role in the 
generation of systemic and local responses to infection, injury, and immunological 
challenges. In mammals, IL-1β is synthesized as an inactive 31 kDa precursor that is 
cleaved by caspase-1 generating a 17.5 kDa secreted active mature form. The caspase-1 
cleavage site strictly conserved in all mammalian IL-1β sequences is absent in those 
reported so far in non-mammalian vertebrates. Recently, fish caspase-1 orthologues have 
been identified in sea bass (Dicentrarchus labrax) and sea bream (Sparus aurata) but 
very little is known regarding its processing and activity. 
In this work it is shown that sea bass caspase-1 auto-processing is similar to that of 
the human enzyme, resulting in active p24/p10 and p20/p10 heterodimers. Moreover, the 
presence of alternatively spliced variants of caspase-1 in sea bass is reported. The 
existence of caspase-1 isoforms in fish and in mammals suggests that they have been 
evolutionarily maintained and therefore are likely to play a regulatory role in the 
inflammatory response, as shown for other caspases. Finally, it is shown that sea bass 
and avian IL-1β are specifically cleaved by caspase-1 at different but phylogenetically 
conserved aspartates, which in turn are distinct from the cleavage site of mammalian IL-
1β. 
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Introduction 
IL-1β is the most studied pro-inflammatory cytokine, much due to its role in mediating 
auto-inflammatory diseases (see e.g., [1-4]). It is mainly produced by activated 
macrophages, monocytes, and dendritic cells and affects almost every cell type, playing a 
central role in the generation of systemic and local responses to infection, injury, and 
immunological challenges, although it can also have detrimental effects (see e.g., [1-6]). 
IL-1β exerts its activity by binding to IL-1 type I receptor (IL-1RI), which then recruits IL-1 
receptor accessory protein (IL-1RAP) forming a complex that triggers a series of 
phosphorylation events leading to the activation of IκB kinase (IKK) and MAPK pathways 
(see e.g., [4, 7, 8]). These signalling pathways activate the transcription factors NF-κB and 
AP-1, resulting in the induction of genes encoding chemokines, cytokines, acute-phase 
proteins, cell adhesion molecules, and enzymes involved in the production of small pro-
inflammatory substances [5]. In mammals, IL-1β is synthesized as an inactive 31 kDa 
signal peptide-less precursor molecule (proIL-1β) [9, 10]. In humans and mice, caspase-1, 
also known as ICE (interleukin-1β converting enzyme) [11-13], specifically cleaves proIL-
1β after aspartate 116 and 117, respectively, yielding a C-terminal 17.5 kDa secreted 
active form [11, 12, 14-18]. Non-caspase-1-mediated cleavage mechanisms generating 
different active forms of IL-1β have also been described (reviewed in [2, 4, 5, 19]). 
IL-1β has been identified in several fish species [20-30]. However, although it was 
reported that processing of IL-1β by a gilthead sea bream fibroblast cell line is abrogated 
by a specific caspase-1 inhibitor [31], neither direct evidence for the participation of 
caspase-1 in this processing event was provided nor the cleavage site in proIL-1β was 
defined. This last issue is particularly important because the caspase-1 cleavage site 
reported for mammalian proIL-1β is absent in the proIL-1β sequences of non-mammalian 
vertebrates. Putative trout [32], sea bass [33], and chicken [34-36] recombinant mature IL-
1β starting respectively at Ala95, Ala86, and Ala106, equivalent sequence-wise to the N-
terminal residue of mature mammalian IL-1β, were shown to be biologically active. 
However, in none of these is the putative mature N-terminal preceded by an aspartate 
residue, making those sites rather improbable caspase-1 cleavage residues. In trout, a 29 
kDa IL-1β precursor expressed in RTS-11 cells was processed to a 24 kDa peptide [37] 
and a 15 kDa band has been detected by Western blotting in PHA activated carp 
leucocyte culture supernatant [38]. However, the mechanism and exact cleavage site of 
processing were not clarified [39-41]. 
Caspase-1 is the prototype of a family of inflammatory caspases that contain a 
caspase recruitment domain (CARD) within their amino-terminal pro-domains (see e.g., 
[5, 42]). Normally, it exists in the cytoplasm as a 45 kDa inactive precursor [43], being 
 
Chapter VI - Sea bass Caspase-1 
 
 
81 
 
 
activated by CARD oligomerization in a multiprotein complex known as the inflammasome 
(see e.g., [44-51]). Once activated, caspase-1 processes the pro-inflammatory cytokines, 
starting an inflammatory response. Caspase-1 was recently found to be also involved in 
pyroptosis, a rapid active cell death programme characterised by early plasma-membrane 
rupture and release of pro-inflammatory intracellular contents ([52]; reviewed in [53, 54]). 
In humans, caspase-1 is activated by cleavage after Asp103, D119, D297 and D316, releasing 
the 11.5 kDa pro-domain and a 2 kDa linker peptide and originating the active heterodimer 
p20/p10 [17, 18, 55-57].  
Fish inflammatory caspases have been primarily sequenced in zebrafish [58] and sea 
bass (GenBank accession no.: DQ198377), the later being a caspase-1 homologue that 
has recently also been reported for sea bream [59] but there is still no functional data from 
these enzymes. Here, the characterisation of the sea bass caspase-1 homologue, its 
processing and activity are reported. It is shown that sea bass caspase-1 auto-processing 
follows the mechanism described for the mammalian enzyme, yielding p24/p10 and 
p20/10 active heterodimers. In addition, three other caspase-1 isoforms have been 
identified. Finally, analysis of sea bass IL-1β processing by active sea bass caspase-1 
revealed that the cytokine is cleaved at a phylogenetically conserved aspartate residue, 
distinct from the cleavage site in birds. 
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Materials and Methods 
Fish  
Sea bass (Dicentrarchus labrax) were kept in a recirculating, ozone-treated salt-water 
(25-30‰) system at 20 ± 1 ºC, and fed at a ratio of 2 % body weight per day. For organ 
collection fish were euthanized with 2-phenoxyethanol (Panreac; >5 ml/10 L).  
This study was carried out in accordance with European and Portuguese legislation 
for the use of animals for scientific purposes (Directive 86/609/EEC; Decreto-Lei 129/92; 
Portaria 1005/92). The work was approved by Direcção Geral de Veterinária, the 
Portuguese authority for animal protection. 
Complementary and genomic DNA cloning and sequencing, southern blotting, sequence 
analysis of caspase-1 and expression analysis of caspase-1 isoforms 
Standard techniques for molecular biology have been used, as described in 
supporting information. 
 Production of recombinant sea bass caspase-1 isoforms 
 The coding region of sea bass caspase-1 isoform 1 was amplified from the pGEM-
T Easy plasmid DNA carrying the full length cDNA using specific primers 
DLCASP1FWNdeI and DLCASP1RVXhoI (Table SII). The PCR product was cloned into 
pGEM-T Easy, the plasmid DNA was digested with NdeI and XhoI (Fermentas), and the 
insert cloned into pET-28a (Novagen) in frame with N- and C-terminal His-tags. 
Recombinant sea bass caspase-1 was expressed in E. coli BL21 Rosetta (DE3) overnight 
at 37 ºC with 1 mM IPTG. The recombinant protein was extracted from bacterial cells as 
inclusion bodies and solubilized with 8 M Urea, 50 mM Tris-HCl, 0.2 M NaCl, 2 mM EDTA 
pH 8.0. The protein was refolded by dilution in 50 volumes of refolding buffer (50 mM 
Taps pH 8.5, 1.5 M Sorbitol, 1 mM TCEP, 24 mM NaCl and 1 mM KCl) overnight at 22 ºC. 
As a control, the refolding process was also performed in the presence of 100 µM of a 
specific caspase-1 inhibitor (Ac-YVAD-CHO, Caspase-1 inhibitor I, Calbiochem). The 
refolded protein was bound to an IMAC column (HisTrap HP, GE Healthcare) in refolding 
buffer. The column was washed with the same buffer supplemented with 10 mM imidazole 
and the protein was then eluted in 4 steps with increasing concentrations of imidazole (50, 
100, 250 and 500 mM). The purified protein was analysed by SDS-PAGE and, after 
blotted onto polyvinylidine difluoride membrane (PVDF), fragments of 24, 20 and 10 kDa 
were subjected to N-terminal Edman sequencing (Proteome Factory AG, Germany), in 
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order to determine the cleavage sites between the large and small subunits of sea bass 
caspase-1.  
The cDNAs encoding caspase-1 isoforms 2, 3 and 4 were obtained with the forward 
primer DLCASP1FWNdeI together with DLISO2/3RVXhoI for isoform 2 and 3 and with 
DLISO4RVXhoI for isoform 4 (Table SII). The cloning strategy, expression, purification 
and refolding protocols were those described for isoform 1, except that isoform 2 was 
cloned in pET-30a (Novagen). 
In vitro processing of caspase-1 isoforms 
Two polyclonal antibodies directed against sea bass caspase-1 were produced 
(Davids Biotechnologie GmbH, Germany). An anti-p10 polyclonal antibody was raised 
against the peptide VHKEKDFISLLSST, and detected all caspase-1 forms containing the 
p10 domain. The antibody produced against the peptide QACRGNAGGAVLVSD 
corresponding to the carboxyl-terminal residues adjacent to the proteolytic cleavage site, 
detected processed forms that were cleaved at the p20 cleavage site (therefore, lacking 
the linker and the small subunit), but did not recognise unprocessed caspase-1. 
Auto-processing of the caspase-1 isoforms was analysed by SDS-PAGE and 
Western blotting. Samples of the isoforms collected after urea solubilisation or after an 
overnight refolding step in the presence or absence of 50-100 µM caspase-1 inhibitor 
were subjected to SDS-PAGE. Proteins in the gels were stained with Coomassie brilliant 
blue or were transferred to nitrocellulose membranes and probed with the rabbit anti-p10 
or anti-p20 antibodies (both at a 1/10000 dilution) for 1 h at room temperature. Goat anti-
rabbit Ig conjugated with alkaline phosphatase (Sigma) was used as the secondary 
antibody and the detection performed using 5-bromo-4-chloro-3-indolyl phosphate/nitro 
blue tetrazolium (BCIP/NBT). 
The ability of active sea bass caspase-1 isoform 1 to process isoforms 2, 3 and 4 was 
tested by incubating 2 µg of the purified isoforms with recombinant active caspase-1 
(p24/p10) at a ratio of 2:1 (w/w) in a caspase-1 substrate buffer (0.1% v/w CHAPS, 0.1 M 
HEPES, 10 % v/w sucrose, 10 mM TCEP, pH 7.5) overnight at 22 ºC. As control, similar 
incubations were performed in the presence of 100 µM caspase-1 inhibitor. The proteins 
in the samples were precipitated with TCA and analysed by SDS-PAGE and Western 
blotting using the anti-p10 and anti-p20 antibodies, as described above, or transferred to a 
PVDF membrane for N-terminal Edman sequencing. 
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Activity of recombinant sea bass caspase-1 isoforms 
The activities of the refolded sea bass caspase-1 isoforms were tested by a 
fluorimetric assay using 0.1-2 µg of enzyme and a specific substrate for caspase-1 (Z-
YVAD-AFC, Caspase-1 substrate VI, Calbiochem). To control cleavage specificity, 100 
μM caspase-1 inhibitor was used. All assays were performed in duplicate. In each 
reaction, 71.5 μl of reaction buffer (0.2% CHAPS, 0.2 M HEPES, 20% sucrose, 29 mM 
DTT, pH 7.5) and 16 μM of caspase-1 substrate were used. The mixtures were incubated 
at 25 ºC and the fluorescence recorded for up to 3 h with 20 min intervals on a Spectra 
Max Gemini XS fluorimeter (Molecular Devices) at an excitation wavelength of 405 nm 
and an emission wavelength of 492 nm. The results were expressed as relative 
fluorescence units (RFU). 
In vitro production of sea bass, chicken and human IL-1β by rabbit reticulocytes lysates 
Sea bass 
Plasmids harboring different IL-1β forms have been produced as detailed below.  
pET23proIL1β[His]: the coding region of sea bass proIL-1β was first amplified by PCR 
with primers DLIL1βFWNde3 and DLIL1βRVXho4 (Table SII) using a pGEX-4T-3 plasmid 
(GE Healthcare) carrying the proIL-1β cDNA (previously amplified from sea bass head 
kidney) as template [23]. The PCR product was purified and cloned into the pGEM-T Easy 
vector. After digestion with NdeI and XhoI, the sea bass proIL-1β was cloned into the 
expression vector pET-23a (Novagen) in frame with a C-terminal His-tag.  
pET-23proIL1β, for producing proIL-1β: the histidine tag from pET-23proIL1β[His] was 
removed by site-directed mutagenesis (QuickChange® Site-Directed Mutagenesis Kit, 
Stratagene) using primers listed in Table SII. 
pET-23proIL1β[D60A], pET-23proIL1β[D100A], pET-23proIL1β[D252A], and pET-
23proIL1β[D100A/D252A], for producing mutated forms of proIL-1β in D60, D100, D252, or 
D100/D252: each aspartate was mutated to alanine by site-directed mutagenesis using pET-
23proIL1β as template and primers listed in Table SII. 
pET-23matureIL1β, for producing mature sea bass IL-1β (from S101 to Q261 and non-
tagged): produced using pET-23proIL1β[His] as template and primers listed in Table SII.  
pET-23matureIL1β[D252A], for producing mature sea bass IL-1β mutated at D252: 
aspartate 252 was mutated to alanine by site-directed mutagenesis using pET-
23matureIL1β as template and primers listed in Table SII. 
Chicken 
The plasmids harboring the coding region of proIL-1β from chicken (GGpGEX-6P-
1proIL1β), duck (APpET28proIL1β), goose (AApET28proIL1β and turkey 
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(MGpET28proIL1β) were kindly provided by Dr. Hsien-Sheng Yin and Dr. Long Huw Lee. 
The coding region of chicken proIL-1β was first amplified by PCR with primers listed in 
Table SII using the plasmid GGpGEX-6P-1proIL1β as template. The PCR product was 
purified and cloned into the pGEM-T Easy vector. After digestion with NdeI and XhoI, the 
chicken proIL-1β was cloned into the expression vector pET-23a (Novagen) rendering 
GGpET23proIL1β. 
GGpET23proIL1β[D77A], GGpET23proIL1β[D80A] and GGpET23proIL1β[D82A] for 
producing mutated forms of chicken proIL-1β in D77, D80 or D82: each aspartate was 
mutated to alanine by site-directed mutagenesis using GGpET23proIL1β as template and 
primers listed in Table SII. 
The cDNAs encoding mature IL-1β (starting at S101) with or without a C-terminal His-
tag were amplified from pET23proIL1β[His] with the forward primer DLIL1BFWNde4 and 
the reverse primers DLIL1BRVXho4 or DLIL1BRVXho1, respectively (Table SII) and 
cloned in pET-23a. 
Human 
HSpCMV-XL5proIL1β[D116A], HSpCMV-XL5proIL1β[D128A] and HSpCMV-
XL5proIL1β[D116A/D128A], for producing mutated forms of human proIL-1β in D116, D128 or 
D116/D128: each aspartate was mutated to alanine by site-directed mutagenesis using an 
IL-1β Human cDNA clone (Origene #SC122566) as template and the primers listed in 
Table SII. 
Regions coding for mature human IL-1β from A117 or from S129 were amplified by PCR 
using the IL-1β Human cDNA clone as template and primers described in Table SII and 
cloned into the NcoI/XhoI restriction sites of pET28a (Novagen), yielding plasmids 
HSpET28mature1IL1β and HSpET28mature2IL1β, respectively. 
The above mentioned plasmids, harboring different IL-1β forms, were used to 
synthesize the respective proteins using the TNT® T7 Quick Coupled 
Transcription/Translation kit (Promega) in the presence of [35S] methionine (specific 
activity >1000 Ci/mmol; PerkinElmer Life Sciences) following the manufacturer's 
instructions. 
Production of recombinant sea bass IL-1β  
His-tagged proIL-1β (proIL-1β[His]) was expressed in E. coli BL21 (DE3) CodonPlus 
at 37 ºC with 1 mM IPTG for 4 h, extracted from bacterial cells as inclusion bodies, 
solubilised as described for recombinant caspase-1 and purified under denaturing 
conditions using His-selectTM Nickel Affinity Gel (Sigma). The protein was then refolded by 
dialysis in three steps against 50 volumes of decreasing concentrations of urea (4 M for 
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12 h, 2 M for 12h, 0 M overnight) in 10 mM sodium phosphate buffer pH 7.2 containing 
184 mM NaCl at 4 ºC. The dialyzed protein was centrifuged at 12000 g and the 
supernatant analysed by SDS- and Native-PAGE.  
The cDNAs encoding mature IL-1β (starting at S101) with or without a C-terminal His-
tag were amplified from pET23proIL1β[His] with the forward primer DLIL1BFWNde4 and 
the reverse primers DLIL1BRVXho4 or DLIL1BRVXho1, respectively (Table SII), cloned in 
pET-23a and expressed in E. coli BL21 (DE3) CodonPlus using the approach described 
for proIL-1β. 
In vitro processing of proIL-1β by caspase-1  
The sea bass 35S-labeled IL-1β forms produced using rabbit reticulocyte lysates were 
incubated at 22 ºC for different periods with recombinant sea bass or human (Sigma) 
active caspase-1, with or without a caspase-1 substrate buffer (0.2% CHAPS, 0.2 M 
HEPES, 20% sucrose, 20 mM TCEP, pH 7.5) and in the presence or absence of 100 µM 
of caspase-1 inhibitor. The same procedure was done for the human and chicken 35S-
labeled IL-1β forms, but incubating overnight at 37 ºC and with or without 250 µM of the 
caspase-1 inhibitor. The duck, turkey and goose 35S-labeled IL-1β forms were also 
incubated with recombinant active sea bass caspase-1 as described for chicken IL-1β. 
Samples were subjected to SDS-PAGE, and transferred to nitrocellulose membrane for 
autoradiography. 
The ability of caspase-1 to process recombinant proIL-1β was tested at 22 ºC by 
mixing recombinant active caspase-1 with recombinant proIL-1β[His] at a ratio of 1:2 (v/v) 
in the caspase-1 substrate buffer, in the presence or absence of 20 µM caspase-1 
inhibitor. The samples were precipitated with TCA and subjected to SDS-PAGE. Proteins 
in the gels were stained with Coomassie brilliant blue for mass spectrometry (MS) 
analysis, or blotted onto a PVDF membrane for N-terminal Edman sequencing, or 
analysed by Western blotting using rabbit anti-sea bass IL-1β or anti-His (Santa Cruz) 
antibodies. For antibody production, dialyzed recombinant proIL-1β[His] was further 
purified on a UNOTM Q column (Bio-Rad) using 20 mM Tris pH 8.0 and 20 mM Tris pH 8.0 
1.0 M NaCl as buffer system. The fractions containing proIL-1β[His] were pooled and 
subjected to SDS-PAGE. The band corresponding to proIL-1β[His] was excised from the 
gel and used to immunize rabbits (Davids Biotechnologie GmbH).  
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Sea bass IL-1β processing in vivo 
Over 20 fish were injected intraperitoneally with 200 µl of Photobacterium damselae 
ssp. piscicida concentrated heat-inactivated extracellular products, prepared as described 
elsewhere [60]. After 3 h, cells from the peritoneal cavity were collected by washing with 
10 ml of HBSS, centrifuged and resuspended in fresh HBSS [61, 62]. Cells were counted, 
diluted to a final concentration of 1x106 cells/ml and incubated for 3 h at 22 ºC in the 
presence or absence of 100 µM caspase-1 inhibitor. One millilitre of cell suspension was 
centrifuged at 400 g, the cell pellet resuspended in gel loading buffer and the proteins in 
the supernatant precipitated with TCA. After SDS-PAGE, samples were analysed by 
Western blotting, using the rabbit anti-IL1β antibody, as described above.  
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Results 
The sea bass caspase-1 transcript is alternatively spliced 
The sea bass caspase-1 gene (GenBank accession number: DQ198377) was found 
to consist of 8 exons and 7 introns (Fig. 1), while the human caspase-1 gene has 10 
exons and 9 introns (Ensembl transcript ID ENST00000260309) and presents much 
longer intronic regions (8266 bp vs. 2318 bp).  
 
FIGURE 1. Schematic representation of the genomic organisation and alternative splicing of sea bass 
caspase-1. The exons are represented by boxes (E1-E8) and introns by a solid line (introns larger than 800 bp 
are represented by an interrupted solid line). Coding and untranslated regions are indicated by white and 
shaded boxes, respectively. Nucleotide numbers are given above the boxes. Caspase-1 domains and 
cleavage sites are schematically represented on top of each transcript. ATG: starting codon; QACRG: 
caspase-1 pentapeptide active-site motif; TGA/TAA: stop codon. Genomic DNA (gDNA) was isolated from 
erythrocytes of a single fish, as described by Stet and co-workers [63]. To obtain the complete caspase-1 
gene, gDNA was amplified using the 5’-UTR primer DLCASP1FWEcoRI and the 3’-UTR primer 
DLCASP1RVEcoRI (Table SII), each containing a restriction site for EcoRI. The obtained PCR product was 
purified, digested with EcoRI (Fermentas) and cloned into the pET-32b vector (Novagen). Plasmid DNAs from 
three independent clones were purified and sequenced.  
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Southern blot analysis suggested that, similar to the mouse and human caspase-1 
genes [64-66], sea bass caspase-1 is a single copy gene (Fig. S1A), although four 
different transcripts encoding sea bass caspase-1 have been detected by RT-PCR using 
specific primers (Fig. 1, S1B and S1C). The corresponding deduced proteins are referred 
to as isoform 1-4 (DilaCASP1iso1-DilaCASP1iso4; GenBank accession numbers 
DQ198376, HQ398873, HQ398874 and HQ398875, respectively). DilaCASP1iso1 
contains the typical caspase family p20 and p10 domain profiles and a caspase family 
active site signature (K257PKIIIIQACRG), as well as a characteristic CARD-containing 
domain. DilaCASP1iso2 and DilaCASP1iso3 have a shorter p10 domain, whereas 
DilaCASP1iso4 contains a longer p20 domain and no p10 (Fig. S1B). All isoforms 
comprise the active center pentapeptide QACRG. 
Pair-wise alignments confirmed the homology of DilaCASP1iso1 with caspase-1 
sequences from other species (Table SI). The phylogenetic tree (Fig. S2) clustered the 
inflammatory and apoptogenic caspases into two different clades. Within the inflammatory 
caspase clade, the fish caspases cluster into a single distinct branch with two subgroups: 
one for sea bass and sea bream caspase-1, and another one for the two caspy 
sequences (caspase-a and -b) from zebrafish.  
Sea bass caspase-1 is activated to p24/p10 and p20/p10 heterodimers in vitro. 
In order to characterise caspase-1 auto-processing and IL-1β activation in fish, a 
recombinant form of sea bass caspase-1 (DilaCASP1iso1) was produced. 
Solubilisation and refolding of recombinant DilaCASP1iso1 from inclusion bodies 
originated three major polypeptides, two corresponding to putative large subunits (p24 
and p20), and one corresponding to a putative small subunit (p10; Fig. 2A). N-terminal 
sequencing of the three polypeptides revealed that they were generated by proteolytic 
cleavage of sea bass caspase-1 after E86, D108 and D304 originating a p24, a p20, and a 
p10 polypeptide, respectively. Both p24/p10 and p20/p10 heterodimers (elutions #2 and 
#3, respectively, in Fig. 2A) displayed activity in a caspase-1 specific fluorimetric assay, 
which was abolished by the caspase-1 inhibitor (Fig. 2B). The more abundant p24/p10 
heterodimer was selected for subsequent experiments. A kinetic analysis of the caspase-1 
refolding process revealed a time-dependent decrease of the higher molecular weight 
forms and an increase of lower molecular weight forms (Fig. 3). The polypeptides 
detected in these experiments as well as the non-linear kinetics of processing, typical of 
an autocatalytic event, are remarkably similar to those described for the human protein 
[56, 57]. 
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FIGURE 2. Recombinant sea bass caspase-1 displays enzymatic activity. (A) Production and purification of 
recombinant sea bass caspase-1. W/o ind: non induced; ON ind: overnight induction; IB: inclusion bodies’ 
fraction; Sol: soluble fraction; Refold: overnight refolding; Unb, Wash and Elution: non-bond, washed and 
eluted (1-4) fractions, respectively, of Ni-NTA chromatography purified refolded caspase-1. The positions of 
the p45, p24, p20 and p10 fragments are indicated. Numbers on the left indicate the position of the molecular 
weight markers in kDa. (B) Enzymatic activity of recombinant p24/p10 and p20/p10 sea bass caspase-1 
heterodimers. p24/p10 and p20/p10 were standardized for 1 µg of p10 and were incubated with a specific 
fluorogenic substrate for caspase-1 in the presence or absence of the caspase-1 inhibitor Ac-YVAD-CHO. 
Hydrolysis of the substrate was followed by fluorimetry and results were expressed as relative fluorescent 
units (RFU).  
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FIGURE 3. In vitro auto-processing of 
sea bass caspase-1. (A) Western 
blotting analysis of in vitro auto-
processing of sea bass caspase-1 
using a polyclonal antibody that 
detects all polypeptides containing 
the p10 domain. (B) Western blotting 
analysis of in vitro auto-processing of 
sea bass caspase-1 using a 
polyclonal antibody that detects only 
caspase-1 fragments that have been 
processed at the p20 cleavage site, 
i.e. that have released the linker plus 
the p10 domain. Soluble: solubilised 
DilaCASP1iso1. Inhib: sample 
incubated for 24 h in the presence of 
the specific caspase-1 inhibitor Ac-
YVAD-CHO. The position of the 
different polypeptide fragments is indicated. Numbers on the left indicate the mass of the molecular weight (M) 
markers in kDa. 
DilaCASP1iso2 and DilaCASP1iso3 have little auto-processing activity but are processed 
by DilaCASP1iso1. 
Considering that all spliced sea bass caspase-1 isoforms contain intact pro- and p20 
domains (which include the active site), recombinant forms of sea bass caspase-1 
isoforms 2, 3 and 4 were produced in order to test their auto-processing activity and/or 
processability by active DilaCASP1iso1 (Fig. 4). In contrast to DilaCASP1iso1, isoforms 2 
and 3 showed auto-processing activity, which was totally absent in isoform 4 (Fig. 4), and 
do not become active by auto-proteolysis during the refolding process, as assessed by the 
fluorimetric assay. Nevertheless, isoforms 2 and 3, but not isoform 4, are readily 
processed by DilaCASP1iso1 (Fig. 4). Additionally, a fragment corresponding to the 
shorter p10 of isoform 2 was also detectable (Fig. 4B). For isoform 3, the shorter p10 
fragment could not be detected probably because it is too small to be detected in these 
gels (Fig. 4A and B). The identity of the fragments was confirmed by N-terminal 
sequencing of p36 (GSSHHHHHHM1ADK; band 1 in Fig. 4A) and p10 (T305LHFVH; band 
2 in Fig. 4A). Fragment 3 was a short fragment from the N-terminus 
(GSSHHHHHHM1ADK; band 3 in Fig. 4A). These results suggest that both isoforms 2 and 
3 are processed by isoform 1, releasing the pro-domain and the p10 plus linker. 
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FIGURE 4. In vitro auto-processing 
and processing of sea bass caspase-
1 isoforms 2, 3 and 4 by isoform 1.  
(A) Coomassie brilliant blue stained 
SDS-PAGE of sea bass 
DilaCASP1iso2 (iso2), 
DilaCASP1iso3 (iso3) or 
DilaCASP1iso4 (iso4) incubated 
alone or in combination with active 
(p24/p10) DilaCASP1iso1 (iso1), in 
the presence or absence of caspase-
1 inhibitor Ac-YVAD-CHO (inhib). N-
terminal sequencing revealed that 
the indicated fragments 1 and 2 
correspond to p36 
(GSSHHHHHHM1ADK) and p10 
(T305LHFVH), respectively. Fragment 
3 corresponds to an N-terminal 
fragment of p45 
(GSSHHHHHHM1ADK). 
(B) Western blotting of the in vitro 
processing of caspase-1 isoforms as 
in A, using the anti-p10 polyclonal 
antibody that detects all polypeptides 
containing the p10 domain. 
(C) Western blotting of the in vitro 
processing of caspase-1 isoforms as 
in A, using the anti-p20 polyclonal 
antibody that detects only caspase-1 
fragments that have been processed 
at the p20 cleavage site, i.e. that 
have released the linker plus the p10 
domain. Numbers on the left indicate 
the mass of the molecular weight 
markers in kDa.  
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In vivo-generated IL-1β is an 18 kDa polypeptide    
Peritoneal leukocytes harvested from stimulated sea bass were incubated ex vivo in 
the presence or absence of a caspase-1 inhibitor. Western blotting analysis with an anti-
sea bass IL-1β antibody showed a specific band with an apparent molecular mass of 18 
kDa in culture supernatants and total extracts of cells incubated ex vivo without caspase-1 
inhibitor (Fig. 5). This band co-migrates with a recombinant putative mature sea bass IL-
1β staring after aspartate D100 (MS101-Q261), an aspartate phylogenetically conserved in all 
available IL-1βs, from sharks to humans (Fig S3).  
 
 
 
 
 
 
FIGURE 5. Sea bass IL-1β processing in vivo.  
(A) Western blotting using the anti-sea bass IL-1β 
polyclonal antibody.  
(B) Ponceau staining showing the protein loading. 
Inhibitor: specific caspase-1 inhibitor Ac-YVAD-
CHO. Recombinant putative mature sea bass IL-
1β (MS101-Q261) was loaded as control. 
Supernatant and Cells denote TCA precipitates of 
the supernatants and cell pellet corresponding to 1 
ml of cell suspension after incubation and 
centrifuging, respectively. Numbers on the left 
indicate the mass of the molecular weight markers 
in kDa. 
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Evolutionary divergence of the caspase-1 cleavage site in proIL-1β 
As several attempts to identify the caspase-1 cleavage site in native mature IL-1β 
have failed, in vitro approaches were used.  
As shown in figure 6, in vitro synthesized sea bass proIL-1β was processed by sea 
bass active caspase-1 in a time-dependent manner giving rise to a band with an apparent 
molecular mass of 18 kDa that, as the in vivo obtained band, co-migrates with the putative 
mature sea bass IL-1β MS101-Q261. Mutation of D100 abolished the generation of the 18 
kDa fragment, with accumulation of higher molecular mass species (Fig. 6), whereas 
mutating D60, an aspartate residue previously suggested as a possible caspase-1 
cleavage site in fish [31], did not affect proIL-1β processing even when incubated with a 
caspase-1 buffer that promotes IL-1β cleavage (Fig. S4A). This suggests that cleavage of 
sea bass proIL-1β by caspase-1 occurs C-terminal to D100.  
 
FIGURE 6. Time-course analysis of in vitro synthesized bass proIL-1β and proIL-1β[D100A] by sea bass 
caspase-1. The same volume of in vitro synthesized proIL1β and proIL-1β[D100A] were used and loaded on 
the gel. Fragments 1, 2 and 3 are labelled. Putative mature in vitro synthesized sea bass IL-1β (MS101-Q261) 
has been loaded as control. Numbers on the left indicate the mass of the molecular weight markers in kDa. 
The duple bands corresponding to the highest molecular weight form (fragment 1) suggested cleavage at the 
C-terminal end of proIL-1β. This interpretation was supported by N-terminal sequencing of fragment 1’ (Fig. 
S4A), which revealed that this fragment has the N-terminal sequence of proIL-1β (M1ESEMKC). Furthermore, 
mutation of D252 results in a proIL-1β protein that no longer yields fragment 1 upon incubation with caspase-1 
(Fig S4C). 
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An 18 kDa fragment was also generated from recombinant proIL-1β (Fig. S4B), 
together with a shorter fragment (fragment 3’) which intensity markedly increased with 
time. N-terminal sequencing of fragments 2’ and 3’ (Fig. S4B) revealed that they start at 
S101EKRSLVLVP, confirming that they originated from a cleavage after D100. Fragment 3’ 
was also processed after D252, as mutating D252 abolished its formation (Fig. S4C). Using 
in vitro synthesized proIL-1β it was found that the appearance of fragment 3’ was time-, 
buffer- and caspase-1 concentration-dependent (Fig. S4A,C,D). Furthermore, only few 
fish species present a slightly longer C-terminal region including potential cleavable 
aspartates (Fig. S3). Together with the lack of detection of fragment 3´ in vivo, these data 
suggest that its appearance may be a consequence of the in vitro conditions, which do not 
completely mimic the in vivo environment.  
As the caspase-1 cleavage site described for mammalian proIL-1β is only present in 
mammals (Fig. S3), it is tempting to speculate that the phylogenetically conserved 
aspartate identified as the caspase-1 cleavage site in sea bass proIL-1β is also the 
residue targeted by caspase-1 in the proIL-1β of non-mammalian vertebrates. To address 
this issue, the processing of in vitro synthesized avian pro-IL1β was investigated. Since 
avian caspase-1 is not available, sea bass or human caspase-1 were used. Both sea bass 
and human caspase-1 processed chicken proIL-1β into a mature IL-1β running in SDS-
PAGE above the 21 kDa marker (Fig. 7A and S5A). A similar fragment was obtained 
when sea bass caspase-1 was incubated with duck, goose or turkey proIL-1β (Fig. S5B). 
Due to its apparent size, this suggested that avian proIL-1β could have been cleaved at 
D77/D80/D82 (sea bass D60), which also align with other phylogenetically conserved 
aspartates (Fig. S3). Site-directed mutagenesis confirmed that D80 is the preferential 
aspartate cleavage site (Fig. 7A). Despite the concerns associated with the use of 
heterologous caspases, both human and sea bass caspase-1 showed cleavage specificity 
when incubated with heterologous proIL-1βs, as supported by the fact that sea bass 
caspase-1 processed human proIL-1β at the specific mammalian caspase-1 cleavage 
site, originating the same mature form obtained by incubation with the human enzyme 
(Fig. 7B). Moreover, despite the presence of several aspartates in the sea bass proIL-1β 
including D60 (putative cleavage site in chicken), D100 and D252 (both targeted by sea bass 
caspase-1 in vitro), the human caspase-1 was unable to cleave sea bass proIL-1β (Fig. 
S5C), suggesting a higher specificity acquired during phylogeny. 
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FIGURE 7.  
Processing of in vitro 
synthesized chicken 
and human proIL-1β 
by sea bass 
caspase-1.  
(A) Processing of in 
vitro synthesized 
chicken proIL-1β and 
mutants by sea bass 
caspase-1. The same 
volume of in vitro 
translated chicken 
proIL-1β, proIL-
1β[D77A], proIL-
1β[D80A] and proIL-
1β[D82A] were loaded 
on the gel. In vitro 
translated putative 
mature chicken IL-1β 
forms (MI119-R267, 
MI122-R267 and MS81-
R267) were loaded as 
controls.  
(B) Processing of in 
vitro synthesized 
human proIL-1β and 
mutants by sea bass 
caspase-1.  
(C) Processing of in 
vitro synthesized 
human proIL-1β and 
mutants by human 
caspase-1. The same 
volume of in vitro 
synthesized proIL-1β, 
proIL-1β[D116A], proIL-1β[D128A] and proIL-1β[D116A/D128A] was loaded on the gel. In vitro translated mature 
human IL-1β (MA117-S269) and human IL-1β form (MS129-S269) starting at S129, homologue to sea bass S101, 
were loaded as controls. Mature forms are highlighted by arrow heads. Numbers on the left indicate the mass 
of the molecular weight markers in kDa. 
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Discussion 
Caspase-1 primary structure has since long been known in humans [17, 18, 66] and 
mice [55, 64], but was only recently determined for two fish, sea bass (GenBank: 
DQ198376 and DQ198377) and sea bream [59]. Comparative analyses of the gene and of 
the primary structure of sea bass caspase-1 indicate that a strikingly conserved structure 
has been kept throughout evolution, suggesting that its function, specificity and 
processing mechanisms are highly conserved from at least teleost fish to mammals.  
In humans, in addition to the caspase-1 isoform α, four mRNA isoforms (β, γ, δ and ε) 
resulting from one or more alternative splicing events have been described [67]. In the 
present work, besides sea bass caspase-1 isoform 1 (DilaCASP1iso1), three alternatively 
spliced mRNAs encoding DilaCASP1iso2, DilaCASP1iso3, and DilaCASP1iso4 were 
identified (Figs. 1 and S1B). Contrary to some of the human isoforms, where the pro-
domain (isoform γ) or both the pro-domain and the region containing the active site 
(isoforms δ and ε) have been deleted [67], all sea bass isoforms contain the pro- and p20 
domains, including the fully conserved active site QACRG sequence. The differences 
introduced by the alternative splicing events in sea bass caspase-1 isoforms are all 
located downstream from the active site, with DilaCASP1iso2 and DilaCASP1iso3 
displaying a shorter p10 domain with a different amino acid sequence at the C-terminal 
end. DilaCASP1iso4 has a longer p20 domain but no p10 (Fig. S1B). The presence of 
alternative transcript variants of caspase-1 in sea bass and humans [68, 69] suggests that 
their existence has been conserved throughout evolution and therefore they are likely to 
play a functional role, as described for other caspase isoforms (see below). 
 Similarly to what has been described for human caspase-1 [17, 56, 57, 70], 
DilaCASP1iso1 is autocatalytically converted in vitro into two active heterodimeric 
complexes consisting of p10 paired either with p24 or p20 (Figs. 2A and 3). Strikingly, as 
for Drosophila melanogaster DRONC [71], sea bass caspase-1 p24 is generated by 
cleavage after a glutamate residue (P1 position) instead of the aspartate described in 
mammalian caspases as an absolute requirement for enzyme specificity [13, 17, 72]. 
Conversion of sea bass recombinant p45 to p20/p10 and p24/p10 heterodimers occurs in 
a time-dependent manner through a series of intermediates resembling the auto-
processing of the human caspase-1 precursor, in which the first step is the cleavage of 
p10 and linker from the p45 form, followed by proteolytic conversion of the resulting p36 
into smaller and more active p20 and p24 forms [56, 57]. Thus, these results suggest that 
processing of pro-caspase-1 through several intermediates has been evolutionarily 
maintained at least from teleost fish to humans. 
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 Sea bass caspase-1 isoforms 2 and 3 display some auto-processing activity, 
although in a much lesser degree than isoform 1. Of notice is that none of the fragments 
resulting from auto-processing of isoforms 2 and 3 correspond to p24, p20 or p10 (Fig. 4B 
and C), explaining why no enzymatic activity could be detected. However, contrary to the 
human isoforms [67], both sea bass isoforms 2 and 3 are processed into their p36, p20 
and shorter p10 subunits by isoform 1. These data do not allow to conclude whether 
isoforms 2 and 3 participate in IL-1β processing or isoform 1 activation in vivo. On the 
other hand, being largely inactive, they may participate in a direct inhibitory mechanism of 
caspase-1, together with DilaCASP1iso4, by competing through CARD-CARD interactions 
for the inflammasome complex that activates caspase-1, as has been proposed for other 
CARD-containing proteins such as COP, INCA, ICEBERG and caspase-12 (reviewed in 
[73]). Alternative isoforms have been implicated in the inhibition of caspase-9 [74-76], and 
more recently also of caspase-3, where a short isoform (caspase-3S) antagonizes its 
apoptotic activity [77], thereby playing a physiological role in regulating cell death. 
Therefore, sea bass caspase-1 isoforms could also play a role in the regulation of the 
inflammatory response. Moreover, processing of isoforms 2 and 3 by isoform 1 released 
shorter p10 fragments, which could compete with normal p10 to generate inhibitory 
p20/short p10 heterodimers, as suggested for human ICEε [67].  
In mammals, IL-1β is a pro-inflammatory cytokine produced as a 31 kDa inactive 
precursor [9, 10] that is processed by caspase-1 cleavage after D116 in humans and D117 in 
mice, yielding a C-terminal secreted active form of 17.5 kDa [11, 12, 14-18]. The primary 
structure of fish proIL-1β is similar to that of the mammalian cytokine [20-30]. However, 
the caspase-1 cleavage site present in all mammalian proIL-1β molecules is absent in the 
proIL-1β sequences reported so far for non-mammalian vertebrates (Fig. S3 and [39-41]), 
and the actual cleavage site has been greatly debated since the identification of the first 
non-mammalian IL-1β [22]. Cleavage of in vitro synthesized and recombinant sea bass 
proIL-1β by caspase-1 suggests that mature sea bass IL-1β results from processing of its 
pro-form at D100 giving rise to an 18 kDa polypeptide, in accordance with the form 
detected in vivo (Fig. 5). 
 In view of the above, it would be tempting to speculate that mammalian IL-1β is the 
exception, rather than the norm, in what concerns proteolytic activation, since an 
aspartate residue corresponding to sea bass D100 is strictly conserved in all other 
vertebrate IL-1β sequences (Fig. S3). Particularly in chicken, this position could 
correspond to the activation site, rather than the alanine residue that was considered for 
the putative mature protein that was structurally characterised [36], as that constitutes an 
improbable caspase-1 cleavage site. However, the results presented here suggest that 
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avian proIL-1βs may not be cleaved at the equivalent sea bass D100, but instead 
preferentially cleaved after D80 (Fig. 7 and S5B), present in another proIL-1β stretch where 
aspartates are phylogenetically well conserved (Fig. S3). In other fish species, fragments 
with different molecular masses have been proposed as putative active IL-1β [31, 37, 38, 
78, 79], and aspartate D60 in sea bream, equivalent to chicken D80, has even been 
suggested as a possible cleavage site, because processing at D60 would generate a 
fragment with a molecular mass consistent with the apparent size (22 kDa) of the IL-1β 
fragment detected by Western blotting in that species [31]. However, not only none of the 
reported studies included amino acid sequencing of the processed IL-1β fragments, but 
mutation of D60 did not affect at all sea bass IL-1β processing (Fig. S4A), in opposition to 
mutation of D100 where IL-1β processing to an 18 kDa form was abrogated (Fig. 6, S4A,C). 
To which extent processing of proIL-1β at this position is the norm among fish remains to 
be elucidated. However, cleavage at D100, here reported for sea bass proIL-1β, will most 
certainly have a significant structural impact in the mature molecule. Homology models of 
mature sea bass IL-1β produced using the available experimental models as templates 
(PDB entries 1IOB (human), 8I1B (mouse) or 2WRY (chicken)) indicate that cleavage at 
D100 would result in the ablation of the N-terminal beta strand, with concomitant 
destabilization of the other beta sheet-forming segment at the C-terminus of the molecule 
(Fig. 8). Therefore, sea bass proIL-1β is certainly structurally distinct in this region, 
although the existing differences cannot be inferred by homology modelling with the 
available templates. 
 
 
 
FIGURE 8. Three-dimensional homology model of sea bass Il-1β (left), and chicken (pdb entry: 2wry; center) 
and human (pdb entry: 1iol; right) 3D structures. All molecules are displayed in the same relative orientation. 
The last β-strand is absent in the sea bass model, destabilizing the pairing C-terminus of the molecule. The 
sea bass molecule was modelled with the Swiss Model server (http://swissmodel.expasy.org/) using the 
experimental coordinates of human IL-1β as template and default parameters. The resulting model had good 
quality indicators. Figure prepared with PyMol (http://www.pymol.org/). 
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Notably, in the mammalian proIL-1β  ca s pa s e-1 leav g  site the P1’ position is 
almost always occupied by a small hydrophobic amino acid, which has been described as 
one of the preferential features of the peptide substrates of mammalian caspase-1 [13, 
17]. On the contrary, most of the aspartates in the putative caspase-1 cleavage sites of 
non-mammalian vertebrates, sequence-wise to sea bass D100 or chicken D80, are not 
followed by a small hydrophobic amino acid. Also of notice is the fact that a small 
hydrophobic amino acid is present in the P1’ position after the phylogenetically conserved 
sea bass caspase-1 cleavage sites in monkeys (A129 in P1’), raising questions about the 
evolutionary driving force that resulted in the appearance of the mammalian cleavage site, 
as the mammalian aspartate at position P1 is only conserved in mammalian IL-1β 
sequences.   
In conclusion, the present work shows that in a teleost fish, pro-caspase-1 auto-
processing occurs through a series of intermediates, yielding active p24/p10 and p20/p10 
heterodimers in a similar way to that described previously for human caspase-1. 
Moreover, the existence of alternative spliced variants of caspase-1 in sea bass is 
reported, suggesting that caspase-1 isoforms have been evolutionarily maintained and 
therefore likely play a regulatory role in the inflammatory response, as shown for isoforms 
of other caspases. Finally, it is shown that sea bass IL-1β is cleaved by caspase-1 at a 
phylogenetically conserved aspartic acid present in all known IL-1β sequences. However, 
in avian proIL-1βs another well phylogenetically conserved aspartate, only absent in 
humans, chimpanzees and zebrafish, may correspond to the cleavage site, suggesting 
that IL-1β processing may be class and/or species specific. Taken together, these results 
confirm that proIL-1β from non-mammalian vertebrates possess a specific caspase-1 
cleavage site. 
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SUPPORTING INFORMATION 
 
Cloning and sequencing of caspase-1 
 Messenger RNA was purified with the MicroPoly(A)PureTM kit (Ambion®) and 
transcribed to cDNA using the SuperscriptTM II First-Strand Synthesis System (Invitrogen). 
PCRs were done according to standard procedures. For amplifying full length sequences 
Pfu DNA polymerase was used in the reactions. DNA sequencing was performed using 
primers detailed in Table SII. Complementary DNAs used for 5’ Rapid Amplification of 
cDNA Ends (5’RACE) experiments were purified using High Pure PCR Product 
Purification Kit reagents (Roche), and used with the 5´RACE System from Invitrogen 
(Version 2.0). The purified cDNA was dATP tailed using Recombinant Terminal 
Transferase (Roche). 
 Messenger RNA (~340 ng) extracted from the head kidney of a fish 1 h after 
stimulation with LPS was reverse transcribed using primer APv (Table SII). Degenerate 
primers were designed based on conserved regions of caspase-1 amino acid sequences 
from different vertebrates. The cDNA was first PCR amplified using primers 
CASP1FW1/CASP1RV1 followed by a semi-nested amplification using primers 
CASP1FW1/CASP1RV2 (Table SII). A third amplification with primers 
CASP1FW1/CASP1RV2 was carried out and a PCR product with the expected size (168 
bp) was purified, cloned and sequenced. This sequence was used to design the specific 
reverse primers DLCASP1RV1, DLCASP1RV2 and DLCASP1RV3 (Table SII), in order to 
obtain the 5’ untranslated region (5´-UTR) using the 5’RACE strategy. The obtained PCR 
product was purified, cloned and sequenced and, because it did not include the start 
codon, the 5’RACE strategy was repeated using again the specific reverse primers 
DLCASP1RV1 and DLCASP1RV2, plus the reverse primer DLCASP1RV5, designed 
based on the sequence obtained from the previous 5’RACE (Table SII). The fragment 
obtained was cloned, sequenced and used to design the specific primer DLCASP1FW7 
(Table SII) in the 5’-UTR. This primer was combined with primer AUAP (Table SII), in a 
PCR aiming to obtain the complete sequence of sea bass caspase-1. Four PCR products 
ranging from 1500 to 1680 bp were purified, cloned into the pGEM-T Easy Vector 
(Promega) and sequenced. 
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FIGURE S1. Caspase-1 is encoded by a single gene in sea bass and encodes at least four different 
transcripts. (A) Southern blotting analysis. Restriction enzymes EcoRI, Spe I, BamHI, NcoI, NdeI, ApaLI (zero 
cutters in sea bass caspase-1 gene), and HindIII and XbaI (single and double cutter in intron 1 of sea bass 
caspase-1 gene, respectively) were used to digest sea bass gDNA from 4 fish, according to the 
manufacturer’s instructions (Fermentas). Digestion products were subjected to 0.8% agarose gel 
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electrophoresis and Southern blotting [2]. A fragment of the sea bass caspase-1 coding region was amplified 
with primers DLCASP1FW4 and DLCASP1RV6 (Table SII). The PCR product (367 bp) was purified as 
previously described, labelled using the Gene ImagesTM AlhPhos DirectTM Labelling and Detection System 
(Amersham Biosciences), and used as probe to detect the caspase-1 gene. For signal generation and 
detection the Chemiluminescent Signal Generation and Detection with CDP-StarTM protocol from the same kit 
was followed. Numbers on the left indicate kbp. (B) Multiple sequence alignment of the predicted primary 
structures of sea bass caspase-1 isoforms and human capase-1α (HosaCASP1alpha). The sequences were 
aligned with CLUSTAL W [1] using default parameters. Domain boundaries were determined with PROSITE 
(www.expasy.org/prosite) and comparison with human capase-1α. Sea bass caspase-1 comprises a pro-
domain (Met1-Asp108), followed by a p20 domain (Gln109-Asp278), a short connecting peptide (Ser279-Asp304), 
and a p10 domain (Thr305-Leu394), and signaled on top of the alignment. The active-site pentapeptide QACRG 
is boxed. The aspartic acid cleavage sites are shaded in gray. Asterisks and “:” and “.” denote identity and 
chemical similarity between amino acids according to the default CLUSTAL W scoring matrix. The amino acid 
residues in the sea bass caspase-1 isoforms 2, 3 and 4 that differ from the isoform 1 are in bold. 
DilaCASP1iso1 (GenBank accession number: DQ198376) has 1663 bp including, as in human and mouse 
caspase-1 mRNA [3, 4], two polyadenylation signals within the 3’-UTR. The ORF encodes a 394 aa long 
protein that, as in the human and mouse sequences, has no hydrophobic signal sequence. Sequence analysis 
revealed that the sea bass protein contains both caspase family p20 and p10 domain profiles and a caspase 
family active site signature (K257PKIIIIQACRG). A pro-domain containing a caspase recruitment domain 
(CARD), typical of pro-inflammatory caspases, is also present. DilaCASP1iso2 (GenBank accession number: 
HQ398873) results from an alternative splicing event involving the utilization of an alternative splicing site 
located within intron 7, which leads to the retention of 31 nucleotides from this intron (Fig. 1). This creates a 
putative caspase-1 isoform containing the complete pro- and p20 domains but having a shorter p10 domain 
(72 aa compared to 90 aa of the full length p10). DilaCASP1iso3 (GenBank accession numbers: HQ398874) 
is generated by an exon skipping event, in which exon 7 is lost (Fig. 1). This creates a putative caspase-1 
isoform containing the complete pro- and p20 domains but having a much shorter p10 domain (25 aa 
compared to 90 aa of the full length p10). DilaCASP1iso4 (GenBank accession number: HQ398875) results 
from two alternative splicing events. One results in the retention of intron 5, generating a stop codon located 
62 nucleotides downstream the beginning of this intron. The other is generated by an exon skipping event, in 
which exon 7 is spliced out of the transcript, as in DilaCASP1iso3 (Fig. 1). This creates a putative caspase-1 
isoform containing a complete pro-domain; however, the splicing originates a shift in the reading frame that 
generates a different coding region after the active center. Although there is an aspartate residue within this 
alternative coding region, it is apparently not used as cleavage site, as this isoform is not auto-processed nor 
processed by active DilaCASP1iso1 (see below), therefore rendering a longer p20 domain (11 aa longer and 
21 aa different) and no p10. (C) Expression analysis of caspase-1 isoforms in sea bass spleen. 
Complementary DNA was synthesized from total RNA extracted from spleens of 9 non-stimulated fish as 
described in supporting information section “cloning and sequencing of caspase-1”. The cDNAs were 
amplified using the forward primer DLCASP1FW11 (designed in an exon/intron boundary) for all isoforms and 
a reverse primer specific for different isoforms (Table SII): isoform1, DLCASP1RV18 (between exon 7 e 8); 
isoform 2, DLCASP1RV16 (intron 7); isoform 3/4m, DLCASP1RV19 (between exon 6 and 8); and isoform 4, 
DLCASP1RV17 (intron 5). The reverse primer DLCASP1RV19 amplifies isoforms 3 and 4 but, in combination 
with the primer DLCASP1FW11, different size products are obtained (989 bp for isoform 3 and 1076 bp for 
isoform 4). The PCR products were purified and sequenced. 
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FIGURE S2. Neighbour-joining tree (MEGA version 3.1) [5] with p-distance and complete deletion of gaps of 
inflammatory (caspase-1, -4, -5, -11 and -12) and apoptogenic (caspase-3 and -9) caspases. The amino acid 
sequences were aligned with CLUSTAL W [1] using the default parameters. The numbers in branching nodes 
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denote the bootstrap percentages for 1000 replicates. The different branches are supported by high bootstrap 
values. GenBank accession numbers: for caspase-1 see Table SI; for caspase1/4: ABX79372 (Canis lupus 
familiaris); for caspase-3: ABC70996 (Dicentrarchus labrax), AAM43816 (Takifugu rubripes), BAB32409 
(Danio rerio), CAC88866 (Homo sapiens), AAH81854 (Rattus norvegicus), AAH38825 (Mus musculus); for 
caspase-4: NP_001216 (H. sapiens), NP_788811 (Bos taurus), NP_446188 (R. norvegicus); for caspase-5: 
ABB58698 (H. sapiens), XP_001100375 (Macaca mulatta); for caspase-9: BAA87905 (H. sapiens), 
AAK26235 (R. norvegicus), AAH56447 (M. musculus), ABC70998 (D. labrax); the sequence of Tetraodon 
nigroviridis putative caspase-9 (CAG01765) was obtained by Blast search of the Genbank database with the 
sequence of sea bass caspase-9 as query; for caspase-11: CAA73531 (M. musculus), AAK38735 (R. 
norvegicus); for caspase-12: AAT91067 (M. musculus), EDL78548 (R. norvegicus), ABG21363 (M. mulatta), 
NP001070704 (C. lupus familiaris), ABX79369 (Felis catus). 
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FIGURE S4. Processing 
of in vitro synthesized 
and recombinant sea 
bass proIL-1β by 
caspase-1. (A) Time-
course processing in 
vitro synthesized sea 
bass proIL-1β 
proIL1β[D60A] and 
proIL1β[D100A] by sea 
bass caspase-1, in the 
presence or absence of 
caspase-1 inhibitor Ac-
YVAD-CHO, using 
caspase-1 buffer. In vitro 
synthesized putative 
mature sea bass IL-1β 
(MS101-Q261) was loaded 
as control. (B) Time-
course processing of 
recombinant sea bass 
proIL-1β by caspase-1 
using caspase-1 buffer. 
proIL-1β[His] (proIL-1β) 
and DilaCASP1iso1 
(Casp1) were loaded as 
controls. On the right, a 
schematic illustration of 
the fragments obtained, 
as concluded from N-
terminal sequencing, is 
shown; capital letters 
denote amino acid 
residues and the 
superscript numbers the 
amino acid position 
within the sea bass IL-1β sequence. (C) Time-course processing of in vitro synthesized sea bass proIL-1β 
proIL1β[D60A] and proIL1β[D100A] using caspase-1 buffer. In vitro synthesized mature sea bass IL-1β (MS101-
Q261) was loaded as control. (D) Processing of in vitro synthesized sea bass proIL-1β with or without caspase-
1 buffer and with different amounts of caspase-1 (relative amount of caspase-1 added to the reaction). In vitro 
synthesized mature sea bass IL-1β (MS101-Q261) was loaded as control. ProIL-1β fragment 1, 2 and 3 are 
indicated in (C) and (D). Numbers on the left (right in D) indicate the mass of the molecular weight markers in 
kDa. The same volume of each in vitro synthesized proIL-1β forms were used and loaded on the gel.  
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FIGURE S5. Processing of in vitro synthesized sea bass and chicken proIL-1β by human and sea bass 
caspase-1, respectively. (A) Chicken proIL-1β is processed by human caspase-1. Putative mature chicken IL-
1β forms (MS81R267, MI119R267 and MI122R267) were loaded as controls. (B) Processing of in vitro synthesized 
chicken, duck, goose and turkey proIL-1β by sea bass caspase-1. Putative mature chicken IL-1β forms 
(MS81R267, MI119R267 and MI122R267) were loaded as controls. (C) Sea bass proIL-1β is not processed by 
human caspase-1. Numbers on the left indicate the mass of the molecular weight markers in kDa. The same 
volume of in vitro synthesized proIL-1β forms for each species was used and loaded on the gel. 
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Table SI. Amino acid sequence conservation for caspase-1 of different species. The percentages of similarity 
and identity were calculated by pair-wise alignments with the program needle [6] as implemented at EBI web 
site (www.ebi.ac.uk) with first and extending gap penalties of 10 and 0.5, respectively. 
 
Species 
Dicentrarchus labrax 
Accession number 
Identity Similarity Gaps 
Sparus aurata 62.7% 76.7% 4.7% CAM32183 
Danio rerio caspy 38.5% 53.4% 19.7% NP_571580 
Danio rerio caspy2 30.7% 45.0% 23.8% NP_690840 
Rattus norvegicus 37.0% 52.3% 10.0% NP_036894 
Mus musculus 37.0% 51.2% 12.1% NP_033937 
Xenopus laevis  XICE-a 36.9% 51.1% 9.3% BAA14017 
Homo sapiens isoform alpha percursor 36.0% 51.1% 8.6% NP_150634 
Felis catus 35.4% 51.6% 11.3% NP_001009365 
Gallus gallus 26.4% 39.1% 31.6% AAC69917 
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Table SII. Primer sequences and application. a R= A/G; Y= C/T; N= A/C/T/G; K= G/T; D=A/G/T; W=A/T; 
S=G/C ; V=A/C/G 
 
Primer Sequencea Application 
APv 5’ – GGCCACGCGTCGACTAGTAC(T17)V – 3’ cDNA synthesis 
AUAP 5’ – GGCCACGCGTCGACTAGTAC – 3’ cDNA amplification 
CASP1FW1 5’ – GARAARGAYGARGARAAYATG – 3’ cDNA amplification 
CASP1RV1 5’ – GACYTTNCKRAANARYTCYTC – 3’ cDNA amplification 
CASP1RV2 5’ – GCCRTGNSWCATDATNACNAC – 3’ cDNA amplification 
DLCASP1FW7 5’ – TCTGAACCAGAGCGCATTAC – 3’ 5’- Racing 
DLCASP1RV1 5’ – CATATCCCAGAGCTTTGAGAAGT – 3’ 5’- Racing 
DLCASP1RV2 5’ – CTCAATCATGGCAGCGTCAA – 3’ 5’- Racing 
DLCASP1RV3 5’ – TGTCAGTCTCCCTGAGTTTC – 3’ 5’- Racing 
DLCASP1RV5 5’ – CTTTCAGGAATCGTGTGGCC – 3’ 5’- Racing 
DLCASP1FWEcoRI 5’ – CGGAATTCTCTGAACCAGAGCGCATTA – 3’ Genomic amplification 
DLCASP1RVEcoRI 5’ – CCGAATTCCGACAGATGGAGCAAACAGTGTG – 3’ Genomic amplification 
DLCASP1FW4 5’ – TGTGGCCCTTCTCATCACTA – 3’ Probe amplification 
DLCASP1RV6 5’ – GGCCTGGATGATGATGATCT – 3’ Probe amplification 
DLCASP1FW11 5’ – AGAAATGGCAGATAAGGAG – 3’ Expression 
DLCASP1RV16 5’ – GAGGACAGTTTGCCCTTAGA – 3’ Expression  
DLCASP1RV17 5’ – CGGAGTGCAAGTTGCAATGT – 3’ Expression 
DLCASP1RV18 5’ – AGCGTTGCATGACTGTTCTG  – 3’ Expression 
DLCASP1RV19 5’ – AAAGCGTTGCATGACCGGGG – 3’ Expression 
DLCASP1FWNdeI 5’ – GGAATTCCATATGGCAGGTAAGGAGCTTTTCAG – 3’ Recombinant production 
DLCASP1RVXhoI 5’ – CCGCTCGAGGCCTGGGAAGAAGTAGAA – 3’ Recombinant production 
DLISO2/3RVXhoI 5’ – CTCGAGAAGCGTTGCATGAC – 3’ Recombinant production 
DLISO4RVXhoI 5’ – ACTCGAGACGGAGTGCAAGT – 3’ Recombinant production 
DLIL1βFWNde3 5’ – AGCAGCATATGGAATCTGAGATGAA – 3’ Recombinant/in vitro translation 
DLIL1βRVXho4 5’ – CCGCTCGAGCTGTCCATTCAAAAGGGG – 3’ Recombinant/in vitro translation 
DLIL1βFWNde4 5’ – CATATGAGCGAAAAGAGGAGCTTAGTTCTG – 3’ Recombinant/in vitro translation 
DLIL1βRVXho1 5’ – GCGCTCGAGTTACTGTCCATTCAAAAGGGGACAA– 3’ Recombinant/in vitro translation 
DLIL1βMUT0FW1 5’ – CCCCTTTTGAATGGACAGTGAGAGCACCACCACCACC – 3’ Site direct mutagenesis (Remove LE6His) 
DLIL1βMUT0RV1 5’ – GGTGGTGGTGGTGCTCTCACTGTCCATTCAAAAGGGG – 3’ Site direct mutagenesis (Remove LE6His) 
DLIL1βD60FW1 5’ – GATGAGCACTGAGTTCAGAGCGGAAAACCTGCTA – 3’ Site direct mutagenesis (D60A) 
DLIL1βD60RV1 5’ – TAGCAGGTTTTCCGCTCTGAACTCAGTGCTCATC – 3’ Site direct mutagenesis (D60A)  
DLIL1βD100FW1 5’ – AATGCAGCGTGACCGCGAGCGAAAAGAGGA – 3’ Site direct mutagenesis (D100A) 
DLIL1βD100RV1 5’ – TCCTCTTTTCGCTCGCGGTCACGCTGCATT – 3’ Site direct mutagenesis (D100A) 
DLIL1βD252FW1 5’ – TCCAACAACTGAGGCGCAAGTTTGTCCC – 3’ Site direct mutagenesis (D252A) 
DLIL1βD252RV1 5’ – GGGACAAACTTGCGCCTCAGTTGTTGGA – 3’ Site direct mutagenesis (D252A) 
HSIL1βD116FW1 5’ – GAGGCTTATGTGCACGCGGCACCTGTACGA – 3’ Site direct mutagenesis (D116A) 
HSIL1βD116RV1 5’ – TCGTACAGGTGCCGCGTGCACATAAGCCTC – 3’ Site direct mutagenesis (D116A) 
HSIL1βD128FW1 5’ – ACTGCACGCTCCGGGCTTCACAGCAAAAAA – 3’ Site direct mutagenesis (D128A) 
HSIL1βD128RV1 5’ – TTTTTTGCTGTGAAGCCCGGAGCGTGCAGT – 3’ Site direct mutagenesis (D128A) 
HSIL1βmat1FWNcoI 5’ – CCCCATGGCACCTGTACGATCACTGAACT – 3’ In vitro translation 
HSIL1βmat1_2RVXhoI 5’ – CGGCTCGAGTCAGGAAGACACAAATTGCAT – 3’ In vitro translation 
HSIL1βmat2FWNcoI 5’ – GACCATGGCGTCACAGCAAAAAAGC – 3’ In vitro translation 
GGIL1βFWNdeI 5’ – GGCATATGGCGTTCGTTCCCGACCTGGAC – 3’ In vitro translation 
GGIL1βRVXhoI 5’ –  TTCTCGAGTCAGCGCCCACTTAGCTTGTAGGT – 3’ In vitro translation 
GGIL1βD77FW 5’ – GAGGCCGAGGAGCAGGGCATTTGCTGACAGCGA – 3’ Site direct mutagenesis (D77A) 
GGIL1βD77RV 5’ – TCGCTGTCAGCAAATGCCCTGCTCCTCGGCCTC – 3’ Site direct mutagenesis (D77A) 
GGIL1βD80FW 5’ – GGGACTTTGCTGCGAGCGACCTGAG – 3’ Site direct mutagenesis (D80A) 
GGIL1βD80RV 5’ – CTCAGGTCGCTCGCAGCAAAGTCCC – 3’ Site direct mutagenesis (D80A) 
GGIL1βD82FW 5’ – AGGGACTTTGCTGACAGCGCACTGAG – 3’ Site direct mutagenesis (D82A) 
GGIL1βD82RV 5’ – CTCAGTGCGCTGTCAGCAAAGTCCCT – 3’ Site direct mutagenesis (D82A) 
GGIL1βmat1FWNdeI 5’ – GGCATATGATCTTCGACATCAACCAGAAGTG – 3’ In vitro translation 
GGIL1βmat2FWNdeI 5’ – GGCATATGATCAACCAGAAGTGCT – 3’ In vitro translation 
GGIL1βmat4FWNdeI 5’ – GGCATATGAGCGACCTGAGCG – 3’ In vitro translation 
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Concluding remarks and future perspectives 
 
 Two decades have passed since the discovery of the first caspase and meanwhile, 
emerging roles of mammalian caspases in different biologic processes have been 
disclosed. When this work started, the information on fish caspases was scarce, with few 
published papers, mainly in zebrafish, and some direct sequence entries available in the 
NCBI database. BLAST search of non-redundant, expressed sequence tags (EST) and 
genomic (Ensembl) databases enabled the identification of several apoptotic molecules in 
fish, including caspases from each different functional group (initiator, executioner and 
pro-inflammatory), as well as proteins involved in their regulation (Annex 1). Given the 
importance of fish research to support the much needed development of aquaculture and 
to study diverse mammalian normal and pathological issues, and given the participation of 
apoptosis [1, 2] and inflammation [3-6] in many biological processes and pathologies in 
vertebrates, research on fish caspases is of obvious relevance. 
 The work presented in this thesis was carried out at the Fish Immunology and 
Vaccinology (FIV) group at IBMC that studies host-pathogen interactions in fish. The 
group has been mainly involved in studying the sea bass (Dicentrarchus labrax) immune 
system as well as its interaction with Photobacterium damselae ssp. piscicida (Phdp), a 
Gram negative bacteria that causes massive mortalities with high economic impact in 
several cultured marine fish species [7]. In this context, it was found that the major virulent 
factor of Phdp is an apoptogenic AB toxin (manuscript in preparation), named apoptosis 
inducing protein of 56 kDa (AIP56) [8, 9] that induces post-apoptotic secondary necrosis 
of sea bass macrophages and neutrophils [8, 9]. It was also demonstrated that inoculation 
of AIP56 replicates the pathology of the Phdp infection. Due to the major role played by 
caspases in apoptosis, cloning and characterising sea bass apoptotic caspases became a 
priority, because it would allow to develop tools to study the involvement of those 
caspases in the Phdp-associated pathology. Indeed, the data presented in Chapters III, IV 
and V confirmed the involvement of caspase-8, -9 and -3 in the Phdp infection. 
Furthermore, it was shown that pro-inflammatory cytokines are involved in the Phdp 
infection and, in particular, increased levels of IL-1β secretion in the initial stages of the 
infection were demonstrated [10]. The mechanism for the processing of IL-1β in mammals 
is well characterised and known to be mediated by caspase-1, which cleaves proIL-1β at 
aspartate residue 116 in the context of the tetrapeptide YVHD originating its biologically 
active mature form of 17 kDa. Although several studies in fish have shown that IL-1β 
participates in inflammatory responses, the mechanism involved in the processing of pro- 
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IL-1β in fish has not been disclosed. Since the sequencing of the first non-mammalian IL-
1β, 13 years ago [11], it became evident that non-mammalian IL-1βs do not have the 
mammalian caspase-1 cleavage site, therefore raising the question of how this cytokine is 
activated in non-mammalian species. Considering this, the sequence of sea bass 
caspase-1 and the study of its involvement in the processing of IL-1β appeared as an 
important issue to be addressed. 
 
I. Sea bass apoptotic caspases  
 As mentioned in the introduction section, the initiator caspases have a critical role 
of transmitting the apoptotic signal through the activation of the executioner caspases and 
of generating the caspase cascade. The initiator caspases of the extrinsic and intrinsic 
pathways, caspase-8 and -9 respectively, as well as the central executioner of apoptosis, 
caspase-3, were identified in sea bass. Although some fish caspase genes have two 
copies (Annex 1), resulting from the early whole-genome duplication in the teleost lineage 
after the divergence from tetrapods about 450 million years ago [12-14], Southern blotting 
analysis suggest that the caspase genes identified in this thesis are present as single 
copies in the sea bass genome. At the molecular level, the obtained sequences of sea 
bass caspase-8, -9 and -3 retain the motifs that are functionally important, such as the 
pentapeptide active-site motif (QACXG) and the cleavage sites at the aspartic acids that 
give rise to the characteristic organisation of caspases in NH2-terminal pro-domain, large 
and small subunits. Moreover, a short pro-domain typical of executioner caspases was 
identified in caspase-3, while long pro-domains characteristic from initiator caspases were 
present in caspases-8 and -9. In the case of sea bass caspase-8, two death effector 
domains (DED) were predicted by bioinformatics analysis. The same approach identified a 
caspase recruitment domain (CARD) in the NH2-terminal pro-domain of sea bass 
caspase-9. As reviewed in the introduction, both DED and CARD are important domains 
involved in protein-protein interactions necessary to mediate dimerization and consequent 
activation of caspase-8 and -9, respectively. The sea bass caspases possess significant 
degrees of similarity to the corresponding sequences from several vertebrates of different 
taxonomic groups. Furthermore, it was shown that sea bass caspase-8, -9 and -3 were 
expressed at low levels in several organs from non-stimulated sea bass and that their 
expressions are up-regulated in the spleen in response to apoptotic stimuli. The data 
gathered from the molecular characterisation of sea bass apoptotic caspases allowed to 
demonstrate that caspase-8, -9 and -3 are activated in peritoneal macrophages and 
neutrophils treated ex vivo with AIP56 and that both the extrinsic and intrinsic pathways 
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are involved in the AIP56-induced apoptosis [15]. Thereby, this work provided information 
that contributed to a better understanding of the biology of fish apoptotic caspases and 
allowed the development of tools that may be used in the study of the mechanisms of 
apoptosis in fish.  
 
II. Sea bass caspase-1 and its involvement in IL-1β processing 
 The work described in this thesis identified, in the sea bass genome, a caspase-1 
gene which primary structure and gene organisation have been conserved through 
evolution. Sea bass caspase-1 pro-form is auto-processed through several intermediates 
in a similar way as its human homolog, resulting in active p24/p10 and p20/p10 
heterodimers. However, similarly to what has been reported for Drosophila melanogaster 
DRONC [16], the exclusive preference for cleavage at an aspartic acid at P1 position 
described for mammalian caspases is not an absolute requirement for sea bass caspase-
1. Also of notice, is the presence of alternative splice variants of sea bass caspase-1 that 
may have a role in the regulation of the inflammatory response as described for other 
caspase isoforms in mammals [17-22]. The important role of the pro-inflammatory 
cytokine IL-1β as a mediator of inflammatory responses has been documented in several 
species of fish [23-26]. In the present thesis (Chapter VI), significant advances in the 
understanding of fish IL-1β processing are presented, through the identification of a 
cleavage site for caspase-1 at an aspartic acid absolutely conserved in all the IL-1β 
sequences reported so far. However, the equivalent sequence-wise aspartate in avian IL-
1βs is not used as cleavage site in birds. Instead, in birds, another phylogenetically 
conserved aspartate, only absent in humans, chimpanzees and zebrafish, is used, 
suggesting that IL-1β processing may be class and/or species specific. These results 
clearly show that proIL-1β from non-mammalian vertebrates have a specific caspase-1 
cleavage site. Moreover, the cleavage at D100, in sea bass proIL-1β, implies significant 
structural changes in the mature sea bass IL-1β when compared to that of mammals and 
chicken. Solving the 3D structure of sea bass IL-1β would help to define the functional 
implications, if any, of a different mature IL-1β structure. 
  
 In conclusion, the sea bass counterparts of mammalian caspases-3, -8 and -9 
were sequenced and characterised, and shown to be expressed/activated upon an 
apoptotic stimulus. The data obtained allowed the production of monospecific polyclonal 
antibodies against peptides form each identified caspase that were shown to be valuable 
tools for monitoring the active forms of the caspases, as exemplified for caspase-1 in 
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Chapter VI. The genetic information as well as the antibodies produced in this work may 
be used to follow the involvement of sea bass caspases in biological processes at genetic 
and proteomic level, under physiological or pathological conditions. Among many 
questions that have been raised by the results obtained during this thesis, four main 
aspects must be highlighted: (i) the cleavage at D100 in sea bass proIL-1β leads to the 
question of whether other fish proIL-1β are also cleaved at an equivalent aspartate 
residue. Cleavage at this aspartate implies significant structural differences in the mature 
sea bass/fish IL-1β, when compared to that of mammals and chicken. Solving the 3D 
structure of sea bass IL-1β would help defining the functional implications of such 
structural differences and would give insights into the evolutionary driving force that has 
led to the appearance of different caspase-1 cleavage sites in proIL-1βs from different 
classes/species of vertebrates. (ii) The involvement of caspase-1 isoforms in the 
processing/regulation of caspase-1 and pro-IL-1β have been neglected. It is very likely 
that, as shown for other caspases, caspase-1 isoforms play an important role in the 
regulation of the inflammasome and consequent secretion of pro-inflammatory cytokines; 
these is an issue that is worth to investigate. (iii) The increasing significance of the 
inflammasomes in different pathologies, such as auto-inflammatory and infectious 
diseases, has been uncovered in recent years. In an attempt to limit the pathogen 
replication, the activation of inflammasomes is accompanied by the induction of pyroptosis 
during infection by several pathogens. However, in fish there are no studies regarding 
inflammasomes or pyroptosis. Thereby, dissecting the molecular mechanisms for 
caspase-1 activation at the inflammasomes as well as to study the interference of 
pathogens with inflammasome function in fish are research fields worth to be pursued. 
Since it is known that there is an increased expression of IL-1β, as well as other 
inflammatory cytokines, during the initial phase of the Phdp infection, it would be 
interesting to investigate the involvement of the inflammasome and the occurrence of 
pyroptosis in the Phdp infections. (iv) The emerging roles of caspases, including in 
embryonic development, monocyte differentiation and regulation of T cell activation as 
well as their participation in the balance between survival and death, show the importance 
of these molecules. Whether fish caspases possess non-apoptotic and non-inflammatory 
functions remains to be investigated. 
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